Literature DB >> 27698385

Photodynamic N-TiO2 Nanoparticle Treatment Induces Controlled ROS-mediated Autophagy and Terminal Differentiation of Leukemia Cells.

Mohammad Amin Moosavi1, Maryam Sharifi1,2, Soroush Moasses Ghafary3,4, Zahra Mohammadalipour1, Alireza Khataee5,6, Marveh Rahmati7, Sadaf Hajjaran1, Marek J Łos8, Thomas Klonisch9, Saeid Ghavami9,10,11.   

Abstract

In this study, we used nitrogen-doped titanium dioxide (N-TiO2) NPs in conjugation with visible light, and show that both reactive oxygen species (ROS) and autophagy are induced by this novel NP-based photodynamic therapy (PDT) system. While well-dispersed N-TiO2 NPs (≤100 μg/ml) were inert, their photo-activation with visible light led to ROS-mediated autophagy in leukemia K562 cells and normal peripheral lymphocytes, and this increased in parallel with increasing NP concentrations and light doses. At a constant light energy (12 J/cm2), increasing N-TiO2 NP concentrations increased ROS levels to trigger autophagy-dependent megakaryocytic terminal differentiation in K562 cells. By contrast, an ROS challenge induced by high N-TiO2 NP concentrations led to autophagy-associated apoptotic cell death. Using chemical autophagy inhibitors (3-methyladenine and Bafilomycin A1), we confirmed that autophagy is required for both terminal differentiation and apoptosis induced by photo-activated N-TiO2. Pre-incubation of leukemic cells with ROS scavengers muted the effect of N-TiO2 NP-based PDT on cell fate, highlighting the upstream role of ROS in our system. In summary, PDT using N-TiO2 NPs provides an effective method of priming autophagy by ROS induction. The capability of photo-activated N-TiO2 NPs in obtaining desirable cellular outcomes represents a novel therapeutic strategy of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27698385      PMCID: PMC5048164          DOI: 10.1038/srep34413

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Nanoparticles (NPs) are particles smaller than 100 nm in size and are of particular interest as cancer therapeutics because they preferentially localize to tumor sites and easily penetrate tissue and cellular barriers. In addition, NPs can be finely-tuned and used for simultaneous therapy and diagnosis (theragnosis)123. Among NPs, titanium dioxide (TiO2) exhibits unique super-photocatalytic properties that can be utilized to kill cancerous cells upon irradiation234. Under ultraviolet (UV)-light illumination, the valence band electrons of TiO2 are excited to the conduction band and the resulting electron holes have the capability of generating various cellular reactive oxygen species (ROS), including hydroxyl radical (OH·), hydrogen peroxide (H2O2), and superoxide (O2−)45. Irradiation-induced generation of ROS by a photosensitizer is called photodynamic therapy (PDT) and has been clinically approved for several diseases, including cancers67. The advantages of PDT compared to other anti-cancer strategies include the lack of known drug resistance and the ability to control ROS production in cancer cells by controlling PDT doses678. The successful use of TiO2 NPs in PDT has been reported for many different types of cancers, such as human cervical adenocarcinoma, hepatocarcinoma, non-small cell lung cancer, and leukemia59101112. However, the biggest obstacle in the clinical application of TiO2-based NPs for PDT is the TiO2 high band-gap energy level (3.2 ev for anatase) that requires excitation with harmful UV radiation (λ < 387 nm)4131415. Doping TiO2 with metals and/or non-metals usually solves this problem and shifts the absorption onset of TiO2 to longer non-toxic wavelengths131415. For example, nitrogen-doping (N-TiO2) shifts the absorption range of TiO2 to longer wavelengths and leads to a remarkable photocatalytic activity under visible light161718. As an improved nano-photosensitizer, N-TiO2 exhibits significant advantages over TiO2 with higher ROS-producing capacity and anti-cancer PDT activity, but its mechanism of action has yet to be fully elucidated181920. Autophagy is a highly conserved process that occurs in response to a variety of stressful conditions and can lead to cell survival and differentiation or cell death, depending on the cellular context and level and type of stress21222324. At the initial steps of this catalytic pathway, large biomacromolecules and/or organelles are sequestered inside of autophagosomes, which fuse with lysosomes to form acidic vesicular organelles (AVOs) and ultimately lead to recycling or degradation of its content21222325. The link between autophagy and cancer is complex. Autophagy can act as tumor suppressor and/or tumor promoter with the outcome depending on disease stage2123. Thus, the blockade and induction of autophagy are both exploited in cancer therapies232627. Hence, drug discovery research currently focuses on the identification of autophagy modulators2326. Recently, a variety of different NPs, including TiO2928, ceria29, iron oxide3031, rare earth oxides32, and carbon nanotubes33, effectively induced autophagy and this was mainly dependent on their physicochemical properties (e.g., dispersing state and size) and subcellular sites of NPs accumulation31323334. Detection of NPs inside autophagosomes suggests the initiation of a cellular mechanism aimed at activating autophagy to degrade the internalized NPs353637. However, oxidative stress pathways (e.g., mitochondrial damage and/or endoplasmic reticulum stress) or alteration of expression of autophagy-related genes have also been reported to be plausible mechanisms of NP-mediated autophagic response30353637. For example, NPs of different chemical composition, such as metal oxides303637, graphene quantum dots38, and fullerenes3039, could evoke autophagy in a photo-activated- and ROS-dependent manner. Regardless of the mechanism(s) of action, autophagy activity of NPs, alone or in combination with chemotherapeutic drugs, promises to improve cancer therapeutic strategies34353637. Patients would greatly benefit from the development of new strategies for the controlled induction of autophagy in cancer cells3537. While nanomaterials are promising candidates for cancer therapy, their molecular mechanisms of action and the optimal conditions for controlling defined cellular outcomes by NPs are unclear3334353637. Recently, we and others, reported that N-TiO2 NPs exhibit remarkable ROS-dependent cytotoxic and apoptotic activities upon visible-light irradiation in several cancerous cell lines, including HeLa and K562 cells181940. In this study, we optimized this NP-based PDT system using visible-light as a safe, remote and controllable stimulator of well-dispersed N-TiO2 NPs to trigger autophagy or other cell responses in K592 human leukemia cells and human peripheral lymphocytes283135. We chose the human leukemia cell line K562 because this experimental model of chronic myelogenous leukemia (CML) enables simultaneous evaluation of multiple cellular outcomes. This includes the differentiation toward different lineages (i.e., erythroid, macrophage and megakaryocyte lineages) and various death modes (i.e., apoptosis, autophagy, necrosis and necroptosis)41. Our results reveal that upon visible-light irradiation of N-TiO2 NPs, an ROS-mediated autophagic response occurred that could be fine-tuned to selectively induce differentiation or apoptosis in leukemia K562 cells.

Results

Characterization of N-TiO2 NPs and cell culture treatment

The physicochemical properties of the synthetized N-TiO2 NPs have been reported in our previous study17 and showed XRD peaks at 2θ = 25.3°, 37.8°, 48.1°, 53.1°, and 55.8° (Fig. 1A), which corresponded to the anatase form of TiO2. The average sizes of N-TiO2 NPs were estimated between 60–80 nm by TEM analysis (Fig. 1B). Dispersing N-TiO2 NPs in deionized water (dH2O) resulted in the formation of aggregates/agglomerates as observed using scanning electron microscopy (SEM; Fig. S1A) and DLS (Fig. S1B). Preparations of N-TiO2 NPs in cell culture medium without any dispersing agents led to slightly higher hydrodynamic size (951 ± 55 nm) than when dispersed in dH2O (773 ± 24 nm; Fig. 1C). These nearly-micron-size aggregates/agglomerates are not recommended for investigating biological effects of NPs because of their cytotoxicity and complex cell delivery pathways4243. Modifications to the surface of NPs or protein adsorption usually result in better dispersion of NPs and consequently prevent these nonspecific cytotoxic effects314244. Upon sonication of the NP dispersion, the addition of 10% FBS minimized the aggregation of N-TiO2 NPs in culture medium (Fig. 1C)4245. When compared to RPMI-1640, the N-TiO2 NPs in the medium stabilized with 10% FBS had, on average, a 10-fold lower hydrodynamic size distribution (92–98 nm), which is suitable for cellular penetration based on previous research141516. Consistent with these results, the measured zeta potential values for well-dispersed N-TiO2 NPs showed more negative charges, which suggest NP disaggregation (Table 1).
Figure 1

Physicochemical characterization of N-TiO2 NPs and their cellular uptake into K562 cells and PBLs.

XRD peak (A) and TEM image (B) of N-TiO2 NPs powder. (C) Characterization of N-TiO2 NPs (1 mg/ml) in aqueous solutions. The average hydrodynamic sizes of NP in cell culture medium (with or without FBS) were measured using DLS, as described in the Materials and Methods. In these experiments, N-TiO2 NPs were dispersed in RPMI-1640 medium and sonicated for 10 min, then vortexed and different concentrations of FBS (0–20%, v/v) were added. Hydrodynamic sizes were analyzed by DLS. (D,E) Analyses of N-TiO2 NP incorporation into the cytoplasm of K562 cells by flow cytometric light scatter. The cells were treated with 10 and 100 μg/ml N-TiO2 under dark conditions for 3 h, and then the fluorescent intensity of both SSC (D,E) and FSC (D,E) was changed and analyzed using flow cytometry in K562 cells and PBLs.

Table 1

Dispersing parameters and cellular uptake of N-TiO2 NPs in cell culture condition.

ParticleAverage diameter (nm)Zeta potential (mV)Mean SSC changes (treated/control)
N-TiO2 in water773 ± 24+1.5 ± 0.6
N-TiO2 in media951 ± 55−9.0 ± 1.55.9 ± 0.5
N-TiO2 (100 μg/ml) in media +10% FBS98 ± 27−16.3 ± 1.47.2 ± 0.9
N-TiO2 (10 μg/ml) in media +10% FBS92 ± 12−19.0 ± 2.16.1 ± 0.6

NPs were dispersed in water or RPMI media with or without fetal bovine serum (FBS; 10%, v/v), then sonicated, vortexed and hydrodynamic sizes and cell surface charges (zeta potential) were measured. For cellular uptake experiments, K562 cells were treated with N-TiO2 for 3 h in the dark, then mean fluorescent intensity (MFI) of SSC (side-scattered light) were analyzed using flow cytometry, and expressed as the fold change of control cell MFI. The results are presented as the mean of three independent replicates ± SD.

The cytoplasmic uptake of well-dispersed NPs by both K562 leukemia cells and isolated peripheral blood lymphocytes was confirmed by flow cytometry and indicated similar uptake of NPs by cancer and normal cells (Fig. 1D,E). A detectable increase in the mean fluorescent intensity (MFI) of SSC and a decrease in FSC (Fig. 1D) were observed after K562 cells were exposed to N-TiO2 NPs for 3 h. This is believed to be a result of light reflection that resulted from cellular NP uptake46. Cellular uptake of well-dispersed N-TiO2 was enhanced further by increasing the NP concentration from 10 to 100 μg/ml in K562 cells (Fig. 1E and Table 1). The fold increase in SSC of K562 cells exposed to well-dispersed N-TiO2 was also higher than aggregated N-TiO2. Thus, dispersed N-TiO2 NPs are more effective in penetrating cells (Table 1). Similar results were obtained when normal PBLs were exposed to different concentrations of N-TiO2 NPs (Fig. 1E). The SSC MFI ratio, which represents cellular uptake of 10 and 100 μg/ml N-TiO2 NPs into PBLs, was 5.8- and 7.3-fold higher than control, respectively (Fig. 1E). Our data revealed that both the degree of NP dispersion and NP concentration affected cellular uptake of N-TiO2 NPs, providing two parameters that can affect NP cellular content and biological responsiveness.

Photo-activated N-TiO2 NPs augment ROS levels and inhibit growth in a light energy- and NP concentration-dependent manner

We have designed a PDT system composed of N-TiO2 NPs as photosensitizer and visible light as a remote stimulator to fine-tune cellular outcomes. We chose the human leukemia cell line K562 because this experimental model of CML allows the simultaneous evaluation of cell differentiation and/or cell death. We studied the cytotoxicity of well-dispersed versus aggregated forms of N-TiO2 and non-doped TiO2 in K562 cells (Fig. 2A). Well-dispersed N-TiO2 had no growth inhibitory effect up to concentrations of 100 μg/ml in the absence of visible light (Fig. 2A). However, the combination of well-dispersed N-TiO2 NPs with visible light resulted in a marked reduction in growth of K562 cells (Fig. 2B), which was incremental with enhancing concentrations of N-TiO2 and increasing light doses (3–24 J/cm2). Irradiation of well-dispersed forms of N-TiO2 (10 μg/ml) for 2.5, 5, 10, and 20 min resulted in a 25 ± 4%, 30 ± 3%, 56 ± 2%, and 60 ± 3% reduction in growth, respectively, compared to control cells as determined after 24 h (Fig. 2B). Visible light alone (Fig. 2B) failed to have a growth inhibitory effect on the cells at up to 10 min of illumination (3–12 J/cm2) and a marginal (15 ± 3%) reduction in cell numbers was observed after 20 min of visible light irradiation (24 J/cm2). The viability of K562 cells remained unaltered at low concentrations of NP and short irradiation times. However, a substantial decrease in cell viability was observed at doses of 10 μg/ml (24 J/cm2 irradiation) and 100 μg/ml (12 and 24 J/cm2 irradiation), suggesting that only high PDT doses were able to initiate cell death responses in K562 cells (Fig. 2C). Thus, these results suggest that induction of cell death could be regulated by both the applied concentration of well-dispersed N-TiO2 NPs and light exposure duration and intensity. Also, anti-cancer effects of well-dispersed N-TiO2 NPs is directly dependent on light irradiation (Fig. S2).
Figure 2

Anti-cancer and ROS producing effects of various concentrations of N-TiO2 and TiO2 NPs alone or in combination with different visible light energy.

(A) The cells were exposed to different concentrations of aggregated and well-dispersed forms of NPs (0.1–500 μg/ml) for 24 h, then the growth inhibition was estimated using the trypan blue exclusion test. All the results are from three independent experiments ± SD, each performed in duplicate. (B,C) The K562 cells were treated with different concentrations of N-TiO2 NPs (0–100 μg/ml) for 3 h, then illuminated with various doses of visible light (for 2.5–20 min) using a 55W Xenon lamp. Growth inhibition (B) and cell death (C) were estimated at 24 h after irradiation. All the results are from four independent experiments ± SD, each performed in triplicate. Statistical analyses of data for each sample are relative to the corresponding control cells (cells that received irradiation without NP). *P < 0.05, **P < 0.01 and ***P < 0.001. (D,E) Effects of different doses of N-TiO2-based PDT in normal and leukemia cells. Three hours after exposing K562 cells and normal PBLs to N-TiO2 (10 and 100 μg/ml), they were subjected to 10 min of irradiation (12 J/cm2), and growth (D) and viability (E) were determined at 24 h after PDT. The results are the means of three independent experiments ± SD and the results are presented as the percent of control cells (cells that received irradiation without NP). For ROS analysis, the PDT-treated cells were collected at 30 min after irradiation and stained with DCFH-DA, and DCF fluorescence intensities were then analyzed on a plate reader fluorimeter (F). The results are expressed as the fold increase (%) in fluorescence intensity (arbitrary unit, a.u.) of control cells. Error bars are the mean ± SD with *P < 0.001 and **P < 0.0001 versus control cells. ROS levels of both K562 and PBL cells were also analyzed using flow cytometry (G) at 30 min after illumination (12 J/cm2) of N-TiO2 (1–100 μg/ml). The peaks from each experiment were for better comparing the changes in MFI of DCF. The results of PBLs are from one representative healthy sample.

To test the selectivity of such treatment for cancer cells, we compared the effect NP concentrations (10 and 100 μg/ml) and PDT (12 J/cm2 or 10 min irradiation) had on K562 with that of human PBLs (Fig. 2D,E). While growth of K562 cells was profoundly inhibited at low NP doses (10 μg/ml), this was not observed in the PBL cells (Fig. 2D). A 48 ± 15% reduction in PBL numbers was observed at high NP concentrations (100 μg/ml), but this was less than the 73 ± 5% reduction seen with K562 cells. Similar to our previous results (Fig. 2C), low PDT failed to significantly affect viability of K562 while an unexpected increase in viability was observed in PBL (Fig. 2E). At high PDT doses (100 μg/ml, 12 J/cm2), viability decreased in both PBL (45 ± 10%) and K562 cells (52 ± 3%). Thus, selective growth inhibition of K562 leukemia cells was achieved at low dose PDT (10 μg/ml, 12 J/cm2) without any adverse effects on normal PBLs. The induction of oxidative stress via direct generation of ROS is a major PDT outcome and also a cause of PDT cytotoxicity6827. To evaluate the effects of N-TiO2-based PDT on ROS production, we measured the intracellular levels of peroxides using DCFH-DA staining of the cells using fluorimetry (Fig. 2F) and flow cytometry (Fig. 2G). Similar to growth inhibition, a concentration-dependent increase in fluorescence DCF intensity was recorded following exposure of K562 and PBL cells to well-dispersed N-TiO2 (Fig. 2F). Flow cytometric analysis for DCF intensity (ROS level) provided a better view on differential effects of N-TiO2-based PDT in PBL and K562 cells (Fig. 2G). While minimal fluorescence signals were registered in PBL from all three healthy volunteers, K562 cells recorded high fluorescence background indicating that endogenous basal levels of ROS were significantly higher in K562 cells than in PBLs. In both cells, DCF intensity increased along with increasing PDT dose levels, but the ROS kinetics and augmentation levels were different in PBL and K562 (Fig. 2G). Higher endogenous ROS levels may explain the increased sensitivity of K562 leukemia cells at lower N-TiO2 NP concentrations. PDT-induced ROS levels surpass a critical threshold level that triggers K562 cell death, whereas PBLs with low endogenous ROS levels are more tolerant.

Different concentrations of photo-activated NPs induce distinct cellular fates

We explored the molecular mechanisms activated by PDT with different concentrations of N-TiO2 that resulted in the induction of distinct cellular outcomes. Morphological changes induced by different NP concentrations (10 and 100 μg/ml) were distinct in K562 cells (Fig. 3) and PBLs (Fig. S3). Following exposure of K562 cells to 10 μg/ml concentrations of photo-activated N-TiO2, some cells acquired significant changes in cell size and cell-to-cell adherence (Fig. 3A), suggesting the occurrence of cellular differentiation. Giemsa staining showed morphological features of megakaryocytes, including large cells with poly-lobulated nuclei, cytoplasm vacuolization and increased nuclear-to-cytoplasm ratio (Fig. 3B). Flow cytometric analyses of PDT-treated cells identified high expression of CD41 (αIIb chain, platelet GPIIb) and CD61 (β3 integrin, platelet GPIIIa), which are typical markers for megakaryocytes and platelets. These changes were found in K562 cells that were exposed to only 10 μg/ml doses of photo-activated N-TiO2 (Fig. 3C). Differentiation toward the erythroid linage was excluded by benzidine staining (Fig. S3).
Figure 3

Effects of different doses of N-TiO2-based PDT on differentiation and apoptosis in K562 cells.

K562 cells were exposed to low (10 μg/ml, 12 J/cm2) and high (100 μg/ml, 12 J/cm2) doses of PDT for 24 h, then morphological changes with (B) or without (A) Wright-Giemsa staining were studied using light microscopy (magnification 60× and 40×, respectively). Arrows indicate polynucleation and giant cells, and arrow heads refers to cytoplasmic vacuolization. (C) The expression of CD41 and CD61 markers were measured after 24-h exposure to PDT with 10 and 100 μg/ml concentrations of NP using flow cytometry with the corresponding antibodies against each antigen. The results are presented as the mean ± SD of three independent experiments. (D) At 24 h after PDT by N-TiO2 (10 and 100 μg/ml), the cells were harvested and Annexin-V/PI double staining was used to detect apoptosis via flow cytometry. Caspase activity (E,F) was also calculated by measuring the absorbance at 405 nm (OD). Following high PDT of K562 cells for 24 h, the cytosolic extracts were collected, incubated with respective caspase substrates, then the activities of caspase-2, −3, −8 and −9 were determined, as described in the Materials and Methods. The data are presented as the OD of cells exposed to high PDT versus control unexposed cells. Only the caspase-9 and -3 activity differed significantly between control and PDT-exposed cells (*P < 0.0001). (F) Time-dependent activities of caspase-9 and −3 were also measured following exposure of K562 cells to high PDT. The activity of caspase-9 and −3 differed significantly after 6 h (*P < 0.001) and 12 h (**P < 0.0001), respectively, from control cells (0 h).

Increased cell debris was observed in K562 cells (Fig. 3A) and PBLs (Fig. S3) exposed to 100 μg/ml photo-activated N-TiO2. Flow cytometric analysis of Annexin-V/PI failed to detect signs of cell death following low PDT (10 μg/ml N-TiO2). However, 100 μg/ml photo-activated N-TiO2 was a potent inducer of apoptotic cell death in both K562 cells (41 ± 8%, Fig. 3D) and PBLs (40 ± 11%, Fig. S3). We measured the activation of caspases involved in death receptor (caspase-2, −8) and mitochondrial (caspase-9) apoptosis pathways. Exposure of K562 to high concentrations of photo-activated N-TiO2 (100 μg/ml) resulted in a significant (P < 0.001) activation of caspase-9 (15.3-fold of control) and −3 (6.7-fold of control), but not caspase-2 and −8 (Fig. 3E). Activation of caspase-9 was first detected at 6 h, it peaked at 24 h, and then activation decreased at 48 h (Fig. 3F). A significant increase in caspase-3 started at 12 h and increased exponentially up to 48 h. This pattern of caspase activation confirmed the involvement of the mitochondrial pathway of apoptosis, where caspase-9 activation results in a marked activation of caspase-31047.

Autophagy is activated following photo-activation of N-TiO2 by visible light

Recent evidence suggests that ROS generated by PDT could result in autophagy induction92728. In our model system, the occurrence of autophagy was first visualized by the formation of AVOs using acridine orange as a fluorescent dye that is specific for acidic compartments4849. Fluorescence microscopy provided morphological confirmation of AVO formation in response to both low and high concentrations of photo-activated N-TiO2 (Fig. 4A) and flow cytometric analysis detected increased red fluorescence between 12–48 h of PDT (Fig. 4A,B). Vigorous PDT induced increased amounts of AOV formation, suggesting that the level of autophagy induction could be fine-tuned, depending on the applied PDT dose (Fig. 4B). Microtubule-associated protein light chain 3 (LC3) is a reliable autophagy marker and was analyzed by Western blotting (Fig. 4C). Upon induction of autophagy, cytosolic LC3 (LC3-I, top band) is cleaved by Atg4 and subsequently conjugated to phosphatidylethanolamine (LC3-II, bottom band) by Atg3, which allows LC3-II to insert into the membrane of autophagosomes2223. LC3-II levels were observed after a 24-h exposure to both low and high PDT (Fig. 4C). Punctate signals of LC3-II were observed in both the cytosol and nucleoplasm of K562 cells exposed to PDT (Fig. 4D). The occurrence of autophagy flux was assessed by the detection of lysosomal marker LAMP2 (lysosome-associated membrane protein 2) (Fig. 4D). We have observed that punctuate LAMP2 co-localizes with cytosolic LC3-II (Fig. 4D). The autophagy flux was further confirmed using the lysosomal proton pump inhibitor bafilomycin A1 (Baf A). Autophagy flux was confirmed by the increased formation of LC3-II following co-treatment with photo-activated N-TiO2 and Baf A1 (Fig. 5A,B). Additionally, both 10 and 100 μg/ml concentrations of photo-activated N-TiO2 induced autophagy in PBLs (Fig. S5). However, the level of autophagy induction following exposure of PBLs to NPs was less than that in K562 cells (Fig. S5A), and the autophagic effects of 10 μg/ml photo-activated N-TiO2 in PBLs was not associated with growth inhibition (Fig. 2D) or morphological changes (Fig. S3).
Figure 4

Autophagic effects of light-irradiated N-TiO2 in K562 cells.

(A) Cells were exposed to N-TiO2 (10 and 100 μg/ml) and irradiated for 10 min. They were then stained with acridine orange (AO) and formation of AVO was detected using light microscopy after 24 h. Flow cytometry was also used for quantification of AVO formation at the same time (A,B). The results were presented as the percentage of FL3/FL1 intensity (mean ± SD). Statistical significance were expressed as *P < 0.0001 **P < 0.0001 compared with corresponding control cells (0 h). (C) The protein expression level of LC3B, a typical marker of autophagy, was monitored at 24 h after exposing K562 cells to photo-activated N-TiO2 (10 and 100 μg/ml) using specific monoclonal antibody by immunoblotting. The actin was used as loading control. Data are representative of one typical experiment. (D) Immunofluorescence staining for LC3-β and LAMP2 (D) in K562 cells exposed to photo-activated N-TiO2 (10 μg/ml) for 24 h. The LC3-β (green) and LAMP2 (red) punctuations and colocalization of LAMP2 with cytosolic LC3 (orange) were detected under a confocal microscope, as described in the Materials and Methods. Nuclei were stained by DAPI (blue).

Figure 5

Effects of autophagy inhibitors on differentiation and cell death induced by N-TiO2-based PDT in K562 cells.

(A,B) The cells were exposed to high PDT (100 μg/ml N-TiO2, 12 J/cm2) in the presence or absence autophagy inhibitors (3-MA, 1 mM or Baf A, 100 nM) for 24 h, and formation of AVO and LC3-β fragmentation were studied using flow cytometry (A) and immunoblotting (the immunoblot is the crop of the band and representative of three experiments which have been run on the same conditions) (B), respectively. (C,D) To study the effects of autophagy inhibition on differentiation, the cells exposed to PDT with 10 μg/ml N-TiO2 (12 J/cm2), and/or autophagy inhibitors (3-MA, or Baf A) for 24 h, then differentiation was evaluated using Wright-Giemsa staining (C) and the percentage of CD41+ cells (D) was calculated using flow cytometry. (E) K562 cells exposed to high PDT (100 μg/ml N-TiO2, 12 J/cm2), in the presence or absence of autophagy inhibitor (3-MA, 1 mM) for 24 h, and apoptosis and cell death were determined using flow cytometry analysis of AnnexinV/PI-positive cells and counting trypan blue-positive cells, respectively. Significant combinations were expressed as *P<0.001 (compared with control untreated cells) and **P < 0.05 and ***P < 0.01 (compared with cells exposed to photo-activated N-TiO2). All data in this Figure are from three independent experiments ± SD, each performed in triplicate.

Induction of autophagy is required for the differentiation and apoptosis induced by photo-activated N-TiO2

To address the importance of early autophagy activation, we used the autophagy inhibitor 3-methyladenine (3-MA), a phosphatidylinositol 3-kinase inhibitor that blocks autophagy at the early stages by sequestering cargo, or Baf A1 that suppresses autophagy at later stages by preventing the phagosome formation. Autophagy inhibition by 3-MA prevented AVO formation (Fig. 5A) and LC3-II accumulation in K562 cells exposed to photo-activated N-TiO2 (Fig. S6). Wright-Giemsa staining indicated that 3-MA blocked the morphological changes resembling megakaryocytic differentiation (Fig. 5C), and this coincided with a noticeable decrease in the percentage of K562 CD41+ cells (P < 0.01) that were treated with a combination of 3-MA and low PDT (Fig. 5D). While Baf A1 (100 nM) blocked late-stage autophagic flux (Fig. 5A,B), it significantly (P < 0.05) increased the differentiating effects of photo-activated N-TiO2, as denoted by morphology (Fig. 5C) and the percentage of CD41+ cells (Fig. 5D). To clarify the cross-talk between autophagy and apoptosis, 3-MA was used in co-treatment with N-TiO2 (100 μg/ml). Notably, 3-MA blocked the number of dead cells (trypan blue-positive cells) induced by photo-activated N-TiO2 (100 μg/ml) and increased viability, suggesting that autophagy acts as a death pathway at 100 μg/ml of photo-activated N-TiO2 (Fig. 5E). Apoptosis was also diminished by 3-MA, which suggests an upstream role of autophagy in the induction of apoptosis. The results suggest an essential requirement for early-stagy autophagy in determining the cellular outcomes induced by N-TiO2-based PDT.

ROS is upstream of autophagy, terminal differentiation and apoptosis in NP-based PDT

To elucidate a link between oxidative stress and the observed cellular outcomes induced by different PDT doses, two ROS scavengers, N-acetyl-L-cysteine (NAC) as a potent inhibitor of H2O2 and thiourea (TU), as an effective scavenger of OH· and H2O2, were used. Pretreatment for 30 min with either scavenger inhibited ROS augmentation (Fig. 6A). This was accompanied by a substantial reduction in annexin V/PI+ apoptotic cells (Fig. 6B). Similar results were obtained after preincubation of PDT exposed cells with TU (Fig. 6B). Moreover, both inhibitors alleviated the differentiation (CD41+ cells) and autophagy (LC3 II lipidation and AVO formation) in K562 cells (Fig. 6B,C), confirming that ROS is the upstream driver of these cellular events. TU, which was less potent than NAC in reducing apoptosis (Fig. 6A), was able to prevent autophagy and differentiation more efficiently than NAC. The mechanism by which PDT by N-TiO2 generates ROS and the impact of different ROS species on cell fate warrants further investigation.
Figure 6

Inhibitory effect of ROS scavengers on cell fate induced by N-TiO2-based PDT.

(A) K562 cells were preincubated with NAC (10 mM) or thiourea (15 mM) for 30 min, and/or exposed to high PDT (100 μg/ml N-TiO2, 12 J/cm2). Thirty minutes later, ROS levels were determined by staining with DCFH-DA and analyzing DCF fluorescence intensities using flow cytometry. (B,C) Effects of ROS scavengers on different cellular outcomes were examined following preincubation of the cells with NAC (10 mM) or thiourea (15 mM) for 30 min and then exposing to N-TiO2-based PDT for 24 h. To analyze apoptosis, cells exposed to high PDT (100 μg/ml N-TiO2, 12 J/cm2) and the percentage of Annexin V/PI-positive cells were determined using flow cytometry. For differentiation, the cells were exposed to photo-activated N-TiO2 (10 μg/ml) and the percentage of CD41+ cells was evaluated using flow cytometry (B). For autophagy, the cells exposed to photo-activated N-TiO2 (10 μg/ml) and AVO formation (B) and up-regulation of LC3 II (C) were assessed using flow cytometry and Western blotting ((the immunoblot is the crop of the band and representative of three experiments which have been run on the same conditions), respectively. All data in this Figure are from three independent experiment ± SD each performed in duplicate. *P < 0.01 and **P < 0.001 compared with cells exposed to photo-activated N-TiO2.

Discussion

Although the intrinsic cytotoxicity of semiconductor metal-oxide NPs, such as TiO2, alone323334 or in combination with PDT192032, has been exploited in anti-cancer therapies, lack of selectivity and uncontrollable cellular outcomes remains a challenge. In this study, we showed a time- and cost-effective PDT17181920 with well-dispersed N-TiO2 NPs that elicited a controlled autophagy response and ROS generation. Unlike most metal oxide, NPs and TiO2 dopants, which are cytotoxic in the absence of light, N-doped TiO2 NPs are biologically inert and non-toxic in the absence of light18192040, and they generate ROS upon visible light irradiation18192021. Aggregation of metal oxide NPs (e.g., TiO2) can profoundly affect their cellular uptake and biological behavior (e.g., autophagy effects) in a hydrodynamic size- and dispersity-dependent manner2831424450. Protein adsorption onto the surfaces of NPs promoted the formation of non-toxic well-dispersed N-TiO2 NPs3142434451, and despite conflicting reports425253, increased cellular uptake in our cell models. The proteins of FBS, such as albumin, can adsorb onto surface of NPs and prevent aggregation in a concentration-dependent manner43 (Fig. 1C). However, it should be note that FBS contains many other supplements such as amino acids, lipids and ions that may interfere with its anti-aggregating potential in some concentrations445054 like the results we observed by adding 20% FBS (Fig. 1C). The cytotoxic effects of metal oxide NPs are mostly mediated by ROS production through their surfaces ability to catalyze oxidation reactions or through damage to cellular organs4918282955. Similar to recent studies1819, we used low concentrations of well-dispersed N-TiO2 NPs (1–100 μg/ml), which became cytotoxic exclusively upon exposure to visible light (Fig. 2). All effects of NPs were blocked by ROS scavengers (Fig. 6), strongly suggesting that oxidative stress and ROS formation are the main trigger for the cellular changes induced by photo-activated N-TiO2. PDT-mediated ROS strategies have been used in cancer therapy67827, with the type and quantity of ROS members produced by PDT being dependent on the light dose and concentrations of the photosensitizer used7827. In addition, PDT conditions have been shown to have an impact on changing cell fates and osteoblast differentiation7. We showed that at constant light energy (12 J/cm2), well-dispersed N-TiO2 NPs generated a cellular ROS response in a concentration-dependent manner, which resulted in distinct cellular outcomes in K562 and PBL cells (Figs 2 and 3). While robust ROS increases above a certain threshold triggered cell death, more subtle cellular responses were induced at low NP doses (10 μg/ml; Fig. 2D,E). This was not the result of different N-TiO2 NP cellular content in both cell types (Fig. 1E), but it may be associated with higher endogenous ROS levels observed in K562 leukemia cells (Fig. 2G). Contrary to normal cells, tumor cells frequently experience chronic oxidative stress and ROS challenges that render them vulnerable to toxic thresholds, while normal cells can maintain redox homeostasis and survive565758. Other contributing factors for the selective toxicity of TiO2 NPs may include differences in mitochondrial activity353639 and lysosomal capacity59 between normal and malignant cells. Autophagy is a desired outcome and a main mechanism involved in NP effects2135363739. We identified early induction of autophagy and functional autophagy flux by photo-activated N-TiO2 in K562. Depending on the type of stress and the cellular micro-environment, autophagy could protect or destroy cells212223526061. In our cell models, these opposing autophagy responses were dependent on the concentration of photo-activated N-TiO2 NPs, with low (10 μg/ml) and high (100 μg/ml) concentrations of N-TiO2 inducing autophagy-dependent differentiation or autophagy-associated apoptosis, respectively (Figs 3 and 4). Different ways have been proposed to trigger an autophagic response via NPs33343562. Our well-dispersed N-TiO2 NPs did not show intrinsic potential to induce autophagy at concentrations below 100 μg/ml (unpublished data), but they were able to induce autophagy by photo-activation stimulated ROS generation (Fig. 6). ROS damage to different macromolecules and organelles can lead to different cellular responses2832333435. Iron oxide and gold-coated iron NPs were reported to elicit high levels of ROS, resulting in mitochondrial dysfunction, autophagy, and apoptosis303435. Similarly, TiO2 NP-generated ROS induces ER stress and mitochondrial damage, which results in autophagic cell death9. PTD using TiO2 NPs was shown to trigger both extrinsic and intrinsic apoptotic pathways in different cell lines55963. In our study, autophagy induced by photo-activated N-TiO2 involved the mitochondrial-dependent apoptosis pathway (Fig. 4). Autophagy induction may directly evoke apoptosis by facilitating activation of caspases or interaction with mediators of apoptotic pathways, such as the BCL2 protein family64. Moreover, autophagy may indirectly influence apoptotic responses via autophagy-dependent degradation of cytotoxic and aggregated proteins64. The importance of nuclear LC3-II puncta observed in our study is not clear, but may involve nuclear-cytoplasmic shuttling of LC3 under cellular stress, which was recently reported6566. In fact, the microtubule-associated protein LC3 has pleiotropic functions by interacting with the guanine nucleotide exchange factor SOS1 and the Ca2+-sensing protein caldendrin, and by regulating fibronectin mRNA levels6566. In addition, a direct interaction of bioactive silica NPs with LC3-II has been recently reported that is associated with autophagy stimulation and osteoblast differentiation67. Future studies will focus on the biological relevance of nuclear accumulation and LC3 shuttling on the cytotoxicity of photo-activated N-TiO2 NPs. Autophagy has an essential role in cell differentiation6869707172. The genetic knockout of autophagy-related (ATG) genes revealed pivotal functions of autophagy during cell differentiation and development72. For example, autophagy plays an upstream role during adipocyte, monocyte, erythroid and neuronal differentiation23686970717273, and it was recently shown to induce megakaryocyte differentiation6971. Autophagy-associated self-digestive processes may aid morphological changes related to differentiation (disappearance of mitochondria and/or nuclei) and cell survival during differentiation687071. Here, we report for the first time the ability of photo-activated N-TiO2 NPs to induce terminal megakaryocyte differentiation in K562 leukemia cells. Upon exposure to low concentrations of photo-activated N-TiO2 NPs, autophagy was essential for megakaryocytic differentiation in K562, and this effect was blocked by the autophagy inhibitor 3-MA (Fig. 5). However, Baf A1 sequesters the late stages of autophagy and enhances megakaryocyte differentiation induced by NP-based PDT (Fig. 5). This may be a result of the accumulation of molecular mediators promoting differentiation, as reported for tetrandrine-induce differentiation73, or it could result from Baf A1-specific effects independent of autophagy74. Autophagy pathways can alter signaling pathways affecting the differentiation state of leukemia cells73 and pharmacological strategies target autophagy activation to promote terminal differentiation and cell death of leukemic cells73757677. Our discovery of the autophagy-dependent differentiating potential of photo-activated N-TiO2 may have therapeutic advantages for certain types of leukemia7678.

Conclusion

We showed the concentration-dependent capability of well-dispersed photo-activated N-TiO2 NPs to induce terminal megakaryocyte differentiation or cell death in K562 leukemia cells. These cellular outcomes depend on intracellular ROS levels and are mediated by autophagy (Fig. 7). In this situation, low PDT doses (10 μg/ml N-TiO2, 12 J/cm2) also increased ROS and autophagy levels in PBLs, but it did not lead to any growth inhibitory or cytotoxic effects in this human normal-cell model. Our combined N-TiO2 NPs and PDT strategy permits preferential targeting and controlled photo-activated induction of ROS and autophagy activation in leukemia cells and may represent a novel therapeutic approach for a broad range of other cancer types.
Figure 7

Schematic overview of the cellular outcomes induced by N-TiO2-based PDT in human leukemia K562 cells and PBLs.

At a constant light energy (12 J/cm2), 10 μg/ml (low dose) and 100 μg/ml (high dose) concentrations of well-dispersed N-TiO2 NPs lead to different increases in basal (inherent) ROS levels in K562 cells and peripheral lymphocytes (PBLs). Depending on levels of ROS generated by PDT, autophagy induction may be associated with megakaryocytic differentiation or apoptosis in K562 cells. While high doses of PDT (100 μg/ml N-TiO2, 12 J/cm2) induced autophagy-associated apoptosis in PBLs, low PDT doses did not lead to any growth inhibitory or cytotoxic effects in this human normal-cell model.

Materials and Methods

Reagents

Pure TiO2 powder (Cotiox KA-100, anatase: >99%) was supplied by Cosmo Chemical Co. (Incheon, South Korea). Urea was purchased from Merck (Darmstadt, Germany). RPMI-1640 cell culture medium and fetal bovine serum (FBS) were purchased from Biosera (East Sussex, UK). Penicillin and streptomycin were obtained from Cinnagen (Tehran, Iran). Culture flask and plates were obtained from SPL Life Science (South Korea). Phytohemagglutinin (PHA), thiourea (TU), N-acetyl-L-cysteine (NAC), trypan blue, Tris-HCl, propidium iodide (PI), acridine orange (AO), 4′,6-diamidino-2-phenylindole (DAPI), 3-methyladenine (3-MA), bafilomycin A1 (Baf A1), Triton X-100, Tween-20, sodium dodecyl sulfate (SDS), dimethylsulfoxide (DMSO), ethylenediaminetetraacetic acid (EDTA), phenylmethylsulphonyl fluoride (PMSF), 2′,7′- dichlorofluoresceindiacetate (DCFH-DA), and protease inhibitors (aprotinin, pepstatin and leupeptin) were obtained from Sigma (Germany).

Synthesis and characterization of N-doped TiO2 NPs

The N-TiO2 NPs were prepared by mechanical mixing of urea with anatase TiO2 powder in a 4:1 ratio, as reported previously17. Briefly, the materials were annealed under air atmosphere for 1 h at 400 °C with a heating rate of 10 °C per minute and cooled to room temperature (RT), then crushed in an agate mortar to obtain a fine light-yellow powder. The crystal phase composition of N-TiO2 NP sample (amounts of the anatase and rutile phases) was determined by X-ray powder diffraction (XRD) using the Siemens X-ray diffractometer D5000 (Siemens AG, Munich, Germany). The size distribution and morphology of sensitized NPs were analyzed by transmission electron microscopy (TEM) (CM 120, Philips, Germany). The hydrodynamic sizes and surface charges of N-TiO2 NPs were determined by dynamic light scattering (DLS) analyzer (Nanotrac Wave model, Microtrac Inc., USA), according to the manufacturer’s instructions. The N-TiO2 stock solutions of 1 mg/ml was prepared in deionized water (dH2O) or RPMI-1640 medium (with or without FBS) and dilutions of 10–100 μg/ml N-TiO2 (in deionized water, RPMI and RPMI + FBS) were used for DLS analysis to prevent multiple scattering.

Cell culture and PDT condition

The authenticated human erythroid leukemia cell line K562 was obtained from the National Cell Bank of Iran (Pasteur Institute, Tehran, Iran). Cells were cultured in RPMI-1640 medium supplemented with FBS (10%, v/v), streptomycin (100 μg/ml) and penicillin (100 U/ml) at 37 °C in a 5% CO2 humidified atmosphere. Normal human peripheral lymphocytes (PBL) from three healthy donors were obtained following gradient centrifugation on Ficoll-Paque PLUS (Sigma, Munich, Germany). Ethics approval was received from the Ethics Committee of the National Institute of Genetic Engineering and Biotechnology (IR.NIGEB.EC.1394.7.27.2)79 and “the methods were carried out in “accordance” with the relevant guidelines (IR.NIGEB.EC.1394.7.27.2) while an informed consent was obtained from all subjects to get PBL”. The PBLs were cultured in RPMI-1640 medium containing 12.5% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. PHA (5 μg/ml) was added to induce proliferation of PBL. For treatment, pure and N-TiO2 NP stock suspensions (1 mg/ml) were prepared in RPMI-1640 medium and ultrasonicated for 10 min. Unless otherwise indicated, FBS was used as a stabilizer to prepare well-dispersed NPs45. Stock suspensions were freshly diluted to different working concentrations in RPMI-1640 medium containing FBS (10%, v/v). For PDT, cells were exposed to various concentrations of NPs in the dark for 3 h, washed with PBS, and re-suspended in fresh medium containing FBS. Cells were irradiated with a Xenon 55 W lamp and an ultraviolet cutoff filter eliminating UV light λ < 400 nm at 20 mW/cm2 resulting in light energies of 3, 6, 12, and 24 J/cm2 for 2.5, 5, 10, and 20 min, respectively.

Treatment condition for inhibitors

For ROS scavengers, TU (15 mM) or NAC (10 mM) were dissolved in RPMI medium and added 30 min before cells were exposed to NPs. For autophagy inhibition, 3-MA (1 mM, dissolved in PBS) or Baf A1 (100 nM dissolved in DMSO) was used in co-treatment with N-TiO2. Stock solution of 3-MA (20 mM) was prepared fresh and used after heating to 55 °C to be dissolved completely.

Cellular uptake of N-TiO2

The uptake of N-TiO2 NPs was measured by flow cytometry46. Side-scattered light (SSC) is usually affected by intracellular structures whereas forward-scattered light (FSC) is normally related to cell size; however, both SSC and FSC also change upon cellular uptake of nanomaterials46. The K562 cells were exposed to different concentrations of well-dispersed N-TiO2 for 3 h, then cells harvested and analyzed by FACS Calibur™ flow cytometer (BD Biosciences, USA). The SSC and FSC were measured in logarithmic and linear scales, respectively.

Cell proliferation and cytotoxicity assay

Cell proliferation and cell death were studied by trypan blue exclusion assay. Briefly, the cells were exposed to different concentrations of NPs in the presence or absence of visible-light for different times and then stained with trypan blue (0.4% mg/ml) and counted. Cell numbers and viability were manually calculated after counting the number of alive (unstained) versus dead (blue-stained) cells using a hematocytometer under inverted light microscopy (Olympus, Japan), as reported previously79.

Benzidine staining

The erythroid differentiation of K562 cells was evaluated by benzidine staining of hemoglobin-producing cells. K562 cells were treated, for 24–48 h, with different concentrations of photo-activated N-TiO2 or GTP (100 μM) as a positive control. Cell pellets were dissolved in 50 μl benzidine solution (0.2% in 0.5 M acetic acid) containing 3% H2O2 solution (30%). The mixture was incubated for 20 min and cells were counted to determine the percent of hemoglobin-containing cells80.

Measurement of ROS level

The intracellular levels of ROS were assayed after staining with the fluorescent probe DCFH-DA by both fluorimeter and flow cytometer devices81. This colorless probe can easily diffuse into cells and quickly form DCHF by esterase cleavage. The trapped DCHF can be oxidized subsequently with ROS, principally H2O2, to produce a fluorescent dichlorofluorescein (DCF) molecule. Briefly, cells were exposed to different concentrations of N-TiO2 NPs for 3 h, washed in PBS and then resuspended in fresh medium. Between 0–60 minutes after PDT, cells were collected, washed in PBS, and incubated with DCFH–DA (25 mg/ml) for 20 min at 37 °C in the dark. The fluorescence intensity of stained cells was determined at an excitation wavelength of 488 nm and emission at 530 nm on a fluorimeter microplate reader (Bio Tek Instruments, Winooski, USA). For flow cytometric evaluation of ROS, the mean fluorescence intensity of DCF was measured at 30 min after PDT using Cyflogic v. 1.2.1.

Cell differentiation assays

For morphological assessment of differentiation, cytospin slides of the cells were stained with Wright-Giemsa solution and observed using light microscopy (Olympus, Japan). Megakaryocytic differentiation was evaluated by staining K562 cells with a CD41 antibody conjugated with fluorescein isothiocyanate (FITC) and phycoerythrin (PE)-labeled CD61 antibodies (Dako, Glostrup, Denmark). Fluorescence signals were recorded and analyzed by Partec PAS flow cytometer (Partec GmbH, Münster, Germany). An isotope that matched the IgG was used as a control for these experiments47.

Colorimetric caspase activity assay

Caspase activity was evaluated using the Apo Target™ Caspase Colorimetric Sampler Kit (Invitrogen Life Technologies; Carlsbad, CA, USA), according to the manufacturer’s instructions. Cytosolic extracts were assayed for their protein concentrations using the Bradford method before being incubated with individual substrates for each caspase (i.e., VDVAD for caspase-2, DEVD for caspase-3, VEID for caspase-6, IETD for caspase-8, and LEHD for caspase-9) labeled with para-nitroaniline (pNA). Cells were washed with PBS and lysed in Tris-HCl buffer, incubated on ice for 10 min and centrifuged for 1 min (10,000 × g). Protein (50 μg) per 50 μl cell lysis buffer (1 mg/ml) was used for each assay in the presence of caspase substrates (200 μM). Upon cleavage by corresponding caspases, pNA absorption was quantified at 405 nm. The results are presented as fold-increase in caspase activity.

Annexin V/ PI apoptosis assay

Apoptosis was quantified using the annexin V-FITC and PI methods and the Dead Cell Apoptosis kit (Invitrogen Life Technologies). Control and PDT-treated cells were washed in cold PBS and diluted in annexin-binding buffer at a density of 106 cells/ml. Following addition of annexin-V FITC (1 μM) and PI (1 mg/ml), cells were incubated for 10 min in the dark at RT, analyzed by Partec Pas flow cytometry47 and separated into 3 groups: Annexin V−/PI− (intact live cells), Annexin V+/PI− (early apoptotic cells) and Annexin V+/PI+ (late apoptotic cells).

Detection of acidic vesicular organelles

Development of acidic vesicular organelles (AVOs) is a morphological feature, and also a marker, of late autophagy and was quantified by acridine orange (AO) staining4849. AO has green fluorescence but once protonated within the acidic compartments of the cells, it emits a bright red fluorescence. Cells (5 × 105/ml) were exposed to photo-activated N-TiO2 for 12–48 h, harvested and stained with AO (100 μg/ml) at RT for 10 min in the dark. Following washing with PBS, images were analyzed with a fluorescence microscope (Olympus, Japan). A portion of the stained cells was resuspended in 500 ml PBS and intensities of both green (FL1, 550 nm) and red (FL3, 650 nm) fluorescence was quantified with a Partec Pas Flow cytometer (Partec GmbH, Münster, Germany). The percentage ratio of FL3/FL1 positive cells (red-to-green fluorescence intensity) was considered to be an indicator of AVO formation.

Immunocytochemistry and confocal microscopy

Cells were seeded on coverslips, exposed to different concentrations of N-TiO2 and 24 h after PDT cells were washed with PBS, fixed in 4% paraformaldehyde in PBS (pH 7.5), and permeabilized for 30 min with 0.5% Tween-20 in 5% BSA blocking solution. For analysis of LC3-β and LAMP2 punctuations, cells were incubated with rabbit polyclonal LC3B antibody (1:300, Cell Signaling, Cat#: 2775) and/or rat monoclonal LAMP2 antibody (1:50, Santa Cruz Biotechnology Cat#: sc-20004) overnight at 4 °C, followed by incubation with a goat anti-rabbit IgG Alexa Fluor 488 (Life Technologies, Cat# A-11070) and goat anti-rabbit IgG Alexa Fluor 546 (Life Technologies, Cat# A11081) for 1 h at RT, respectively. Images were captured using a Leica CTRMIC 6000 confocal microscope equipped with a Hamamatsu C910013 spinning disc camera (Leica Microsystems Inc., Wetzlar, Germany) and analyzed using Velocity software.

Western blotting

Cells were lysed on ice in NaCl (150 mM), sodium deoxycholate (0.5%), SDS (0.1%), Tris-HCl (50 mM, pH 7.4), Triton X-100 (1%), EDTA (1 mM), EGTA (1 mM), NaF (1 mM), Na3VO4 (2 mM), sodium pyrophosphate (20 mM), sodium deoxycholate (0.5%), PMSF (1 mM), aprotinin (50 μg/ml), leupeptin (10 μg/ml), and pepstatin (1 μg/ml). Forty to fifty micrograms of protein was used for SDS-polyacrylamide gel electrophoresis and protein transfer onto nitrocellulose membrane (Whatman, UK). Membranes were blocked with Tris-buffered saline (pH 7.4) containing 5% fat-free milk powder and Tween-20 (0.2%) for 2–3 h at RT4781 and incubated with the anti-beta actin (ab8227), and anti-LC3B (ab51520) monoclonal antibodies (Abcam, Cambridge, MA, USA) overnight at 4 °C. Membranes were washed 3 times in PBS-Tween-20 (0.2%) and incubated between 1–2 h at RT with appropriate horseradish peroxidase-conjugated secondary antibodies (1:10.000; Sigma). Protein bands were visualized using an enhanced chemiluminescence kit (Amersham Life Sciences, UK).

Statistical analysis

Data are expressed as the mean ± standard deviation (SD) of at least three independent experiments, each performed in duplicate or triplicate. The statistically significant differences (P < 0.05) were analyzed using student’s t-test and ANOVA by Microsoft Excel 2013 (Microsoft, Washington, USA) and GraphPad Prism 5.03 software (La Jolla, CA, USA).

Additional Information

How to cite this article: Moosavi, M. A. et al. Photodynamic N-TiO2 Nanoparticle Treatment Induces Controlled ROS-mediated Autophagy and Terminal Differentiation of Leukemia Cells. Sci. Rep. 6, 34413; doi: 10.1038/srep34413 (2016).
  74 in total

Review 1.  Methods for monitoring autophagy.

Authors:  Noboru Mizushima
Journal:  Int J Biochem Cell Biol       Date:  2004-12       Impact factor: 5.085

Review 2.  The role of autophagy in cancer development and response to therapy.

Authors:  Yasuko Kondo; Takao Kanzawa; Raymond Sawaya; Seiji Kondo
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

Review 3.  Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments.

Authors:  Justin G Teeguarden; Paul M Hinderliter; Galya Orr; Brian D Thrall; Joel G Pounds
Journal:  Toxicol Sci       Date:  2006-11-10       Impact factor: 4.849

Review 4.  Autophagy: from phenomenology to molecular understanding in less than a decade.

Authors:  Daniel J Klionsky
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

5.  Induction of cytotoxicity by photoexcited TiO2 particles.

Authors:  R Cai; Y Kubota; T Shuin; H Sakai; K Hashimoto; A Fujishima
Journal:  Cancer Res       Date:  1992-04-15       Impact factor: 12.701

6.  The inherent cellular level of reactive oxygen species: one of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide.

Authors:  J Yi; F Gao; G Shi; H Li; Z Wang; X Shi; X Tang
Journal:  Apoptosis       Date:  2002-06       Impact factor: 4.677

7.  Visible-light photocatalysis in nitrogen-doped titanium oxides.

Authors:  R Asahi; T Morikawa; T Ohwaki; K Aoki; Y Taga
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

8.  GTP induces S-phase cell-cycle arrest and inhibits DNA synthesis in K562 cells but not in normal human peripheral lymphocytes.

Authors:  Mohammad Amin Moosavi; Razieh Yazdanparast; Abbas Lotfi
Journal:  J Biochem Mol Biol       Date:  2006-09-30

9.  Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique.

Authors:  Richard C Murdock; Laura Braydich-Stolle; Amanda M Schrand; John J Schlager; Saber M Hussain
Journal:  Toxicol Sci       Date:  2007-09-13       Impact factor: 4.849

10.  ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.

Authors:  Mohammad Amin Moosavi; Razieh Yazdanparast; Abbas Lotfi
Journal:  Int J Biochem Cell Biol       Date:  2007-05-04       Impact factor: 5.085

View more
  27 in total

Review 1.  New insights on the role of autophagy in the pathogenesis and treatment of melanoma.

Authors:  Marveh Rahmati; Shiva Ebrahim; Saadeh Hashemi; Masoumeh Motamedi; Mohammad Amin Moosavi
Journal:  Mol Biol Rep       Date:  2020-10-09       Impact factor: 2.316

2.  Inhibition of Autophagy Flux Promotes Secretion of Chondroitin Sulfate Proteoglycans in Primary Rat Astrocytes.

Authors:  Javad Alizadeh; Matthew M Kochan; Vanessa D Stewart; Dennis A Drewnik; Sari S Hannila; Saeid Ghavami
Journal:  Mol Neurobiol       Date:  2021-08-27       Impact factor: 5.590

Review 3.  Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles.

Authors:  Reza Mohammadinejad; Mohammad Amin Moosavi; Shima Tavakol; Deniz Özkan Vardar; Asieh Hosseini; Marveh Rahmati; Luciana Dini; Salik Hussain; Ali Mandegary; Daniel J Klionsky
Journal:  Autophagy       Date:  2018-09-13       Impact factor: 16.016

4.  Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

Authors:  Daniel J Klionsky; Amal Kamal Abdel-Aziz; Sara Abdelfatah; Mahmoud Abdellatif; Asghar Abdoli; Steffen Abel; Hagai Abeliovich; Marie H Abildgaard; Yakubu Princely Abudu; Abraham Acevedo-Arozena; Iannis E Adamopoulos; Khosrow Adeli; Timon E Adolph; Annagrazia Adornetto; Elma Aflaki; Galila Agam; Anupam Agarwal; Bharat B Aggarwal; Maria Agnello; Patrizia Agostinis; Javed N Agrewala; Alexander Agrotis; Patricia V Aguilar; S Tariq Ahmad; Zubair M Ahmed; Ulises Ahumada-Castro; Sonja Aits; Shu Aizawa; Yunus Akkoc; Tonia Akoumianaki; Hafize Aysin Akpinar; Ahmed M Al-Abd; Lina Al-Akra; Abeer Al-Gharaibeh; Moulay A Alaoui-Jamali; Simon Alberti; Elísabet Alcocer-Gómez; Cristiano Alessandri; Muhammad Ali; M Abdul Alim Al-Bari; Saeb Aliwaini; Javad Alizadeh; Eugènia Almacellas; Alexandru Almasan; Alicia Alonso; Guillermo D Alonso; Nihal Altan-Bonnet; Dario C Altieri; Élida M C Álvarez; Sara Alves; Cristine Alves da Costa; Mazen M Alzaharna; Marialaura Amadio; Consuelo Amantini; Cristina Amaral; Susanna Ambrosio; Amal O Amer; Veena Ammanathan; Zhenyi An; Stig U Andersen; Shaida A Andrabi; Magaiver Andrade-Silva; Allen M Andres; Sabrina Angelini; David Ann; Uche C Anozie; Mohammad Y Ansari; Pedro Antas; Adam Antebi; Zuriñe Antón; Tahira Anwar; Lionel Apetoh; Nadezda Apostolova; Toshiyuki Araki; Yasuhiro Araki; Kohei Arasaki; Wagner L Araújo; Jun Araya; Catherine Arden; Maria-Angeles Arévalo; Sandro Arguelles; Esperanza Arias; Jyothi Arikkath; Hirokazu Arimoto; Aileen R Ariosa; Darius Armstrong-James; Laetitia Arnauné-Pelloquin; Angeles Aroca; Daniela S Arroyo; Ivica Arsov; Rubén Artero; Dalia Maria Lucia Asaro; Michael Aschner; Milad Ashrafizadeh; Osnat Ashur-Fabian; Atanas G Atanasov; Alicia K Au; Patrick Auberger; Holger W Auner; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Yenniffer Ávalos; Sanja Aveic; Célia Alexandra Aveleira; Tamar Avin-Wittenberg; Yucel Aydin; Scott Ayton; Srinivas Ayyadevara; Maria Azzopardi; Misuzu Baba; Jonathan M Backer; Steven K Backues; Dong-Hun Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Ahruem Baek; Seung-Hoon Baek; Sung Hee Baek; Giacinto Bagetta; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xiyuan Bai; Yidong Bai; Nandadulal Bairagi; Shounak Baksi; Teresa Balbi; Cosima T Baldari; Walter Balduini; Andrea Ballabio; Maria Ballester; Salma Balazadeh; Rena Balzan; Rina Bandopadhyay; Sreeparna Banerjee; Sulagna Banerjee; Ágnes Bánréti; Yan Bao; Mauricio S Baptista; Alessandra Baracca; Cristiana Barbati; Ariadna Bargiela; Daniela Barilà; Peter G Barlow; Sami J Barmada; Esther Barreiro; George E Barreto; Jiri Bartek; Bonnie Bartel; Alberto Bartolome; Gaurav R Barve; Suresh H Basagoudanavar; Diane C Bassham; Robert C Bast; Alakananda Basu; Henri Batoko; Isabella Batten; Etienne E Baulieu; Bradley L Baumgarner; Jagadeesh Bayry; Rupert Beale; Isabelle Beau; Florian Beaumatin; Luiz R G Bechara; George R Beck; Michael F Beers; Jakob Begun; Christian Behrends; Georg M N Behrens; Roberto Bei; Eloy Bejarano; Shai Bel; Christian Behl; Amine Belaid; Naïma Belgareh-Touzé; Cristina Bellarosa; Francesca Belleudi; Melissa Belló Pérez; Raquel Bello-Morales; Jackeline Soares de Oliveira Beltran; Sebastián Beltran; Doris Mangiaracina Benbrook; Mykolas Bendorius; Bruno A Benitez; Irene Benito-Cuesta; Julien Bensalem; Martin W Berchtold; Sabina Berezowska; Daniele Bergamaschi; Matteo Bergami; Andreas Bergmann; Laura Berliocchi; Clarisse Berlioz-Torrent; Amélie Bernard; Lionel Berthoux; Cagri G Besirli; Sebastien Besteiro; Virginie M Betin; Rudi Beyaert; Jelena S Bezbradica; Kiran Bhaskar; Ingrid Bhatia-Kissova; Resham Bhattacharya; Sujoy Bhattacharya; Shalmoli Bhattacharyya; Md Shenuarin Bhuiyan; Sujit Kumar Bhutia; Lanrong Bi; Xiaolin Bi; Trevor J Biden; Krikor Bijian; Viktor A Billes; Nadine Binart; Claudia Bincoletto; Asa B Birgisdottir; Geir Bjorkoy; Gonzalo Blanco; Ana Blas-Garcia; Janusz Blasiak; Robert Blomgran; Klas Blomgren; Janice S Blum; Emilio Boada-Romero; Mirta Boban; Kathleen Boesze-Battaglia; Philippe Boeuf; Barry Boland; Pascale Bomont; Paolo Bonaldo; Srinivasa Reddy Bonam; Laura Bonfili; Juan S Bonifacino; Brian A Boone; Martin D Bootman; Matteo Bordi; Christoph Borner; Beat C Bornhauser; Gautam Borthakur; Jürgen Bosch; Santanu Bose; Luis M Botana; Juan Botas; Chantal M Boulanger; Michael E Boulton; Mathieu Bourdenx; Benjamin Bourgeois; Nollaig M Bourke; Guilhem Bousquet; Patricia Boya; Peter V Bozhkov; Luiz H M Bozi; Tolga O Bozkurt; Doug E Brackney; Christian H Brandts; Ralf J Braun; Gerhard H Braus; Roberto Bravo-Sagua; José M Bravo-San Pedro; Patrick Brest; Marie-Agnès Bringer; Alfredo Briones-Herrera; V Courtney Broaddus; Peter Brodersen; Jeffrey L Brodsky; Steven L Brody; Paola G Bronson; Jeff M Bronstein; Carolyn N Brown; Rhoderick E Brown; Patricia C Brum; John H Brumell; Nicola Brunetti-Pierri; Daniele Bruno; Robert J Bryson-Richardson; Cecilia Bucci; Carmen Buchrieser; Marta Bueno; Laura Elisa Buitrago-Molina; Simone Buraschi; Shilpa Buch; J Ross Buchan; Erin M Buckingham; Hikmet Budak; Mauricio Budini; Geert Bultynck; Florin Burada; Joseph R Burgoyne; M Isabel Burón; Victor Bustos; Sabrina Büttner; Elena Butturini; Aaron Byrd; Isabel Cabas; Sandra Cabrera-Benitez; Ken Cadwell; Jingjing Cai; Lu Cai; Qian Cai; Montserrat Cairó; Jose A Calbet; Guy A Caldwell; Kim A Caldwell; Jarrod A Call; Riccardo Calvani; Ana C Calvo; Miguel Calvo-Rubio Barrera; Niels Os Camara; Jacques H Camonis; Nadine Camougrand; Michelangelo Campanella; Edward M Campbell; François-Xavier Campbell-Valois; Silvia Campello; Ilaria Campesi; Juliane C Campos; Olivier Camuzard; Jorge Cancino; Danilo Candido de Almeida; Laura Canesi; Isabella Caniggia; Barbara Canonico; Carles Cantí; Bin Cao; Michele Caraglia; Beatriz Caramés; Evie H Carchman; Elena Cardenal-Muñoz; Cesar Cardenas; Luis Cardenas; Sandra M Cardoso; Jennifer S Carew; Georges F Carle; Gillian Carleton; Silvia Carloni; Didac Carmona-Gutierrez; Leticia A Carneiro; Oliana Carnevali; Julian M Carosi; Serena Carra; Alice Carrier; Lucie Carrier; Bernadette Carroll; A Brent Carter; Andreia Neves Carvalho; Magali Casanova; Caty Casas; Josefina Casas; Chiara Cassioli; Eliseo F Castillo; Karen Castillo; Sonia Castillo-Lluva; Francesca Castoldi; Marco Castori; Ariel F Castro; Margarida Castro-Caldas; Javier Castro-Hernandez; Susana Castro-Obregon; Sergio D Catz; Claudia Cavadas; Federica Cavaliere; Gabriella Cavallini; Maria Cavinato; Maria L Cayuela; Paula Cebollada Rica; Valentina Cecarini; Francesco Cecconi; Marzanna Cechowska-Pasko; Simone Cenci; Victòria Ceperuelo-Mallafré; João J Cerqueira; Janete M Cerutti; Davide Cervia; Vildan Bozok Cetintas; Silvia Cetrullo; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Oishee Chakrabarti; Tapas Chakraborty; Trinad Chakraborty; Mounia Chami; Georgios Chamilos; David W Chan; Edmond Y W Chan; Edward D Chan; H Y Edwin Chan; Helen H Chan; Hung Chan; Matthew T V Chan; Yau Sang Chan; Partha K Chandra; Chih-Peng Chang; Chunmei Chang; Hao-Chun Chang; Kai Chang; Jie Chao; Tracey Chapman; Nicolas Charlet-Berguerand; Samrat Chatterjee; Shail K Chaube; Anu Chaudhary; Santosh Chauhan; Edward Chaum; Frédéric Checler; Michael E Cheetham; Chang-Shi Chen; Guang-Chao Chen; Jian-Fu Chen; Liam L Chen; Leilei Chen; Lin Chen; Mingliang Chen; Mu-Kuan Chen; Ning Chen; Quan Chen; Ruey-Hwa Chen; Shi Chen; Wei Chen; Weiqiang Chen; Xin-Ming Chen; Xiong-Wen Chen; Xu Chen; Yan Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Yue-Qin Chen; Zhefan Stephen Chen; Zhi Chen; Zhi-Hua Chen; Zhijian J Chen; Zhixiang Chen; Hanhua Cheng; Jun Cheng; Shi-Yuan Cheng; Wei Cheng; Xiaodong Cheng; Xiu-Tang Cheng; Yiyun Cheng; Zhiyong Cheng; Zhong Chen; Heesun Cheong; Jit Kong Cheong; Boris V Chernyak; Sara Cherry; Chi Fai Randy Cheung; Chun Hei Antonio Cheung; King-Ho Cheung; Eric Chevet; Richard J Chi; Alan Kwok Shing Chiang; Ferdinando Chiaradonna; Roberto Chiarelli; Mario Chiariello; Nathalia Chica; Susanna Chiocca; Mario Chiong; Shih-Hwa Chiou; Abhilash I Chiramel; Valerio Chiurchiù; Dong-Hyung Cho; Seong-Kyu Choe; Augustine M K Choi; Mary E Choi; Kamalika Roy Choudhury; Norman S Chow; Charleen T Chu; Jason P Chua; John Jia En Chua; Hyewon Chung; Kin Pan Chung; Seockhoon Chung; So-Hyang Chung; Yuen-Li Chung; Valentina Cianfanelli; Iwona A Ciechomska; Mariana Cifuentes; Laura Cinque; Sebahattin Cirak; Mara Cirone; Michael J Clague; Robert Clarke; Emilio Clementi; Eliana M Coccia; Patrice Codogno; Ehud Cohen; Mickael M Cohen; Tania Colasanti; Fiorella Colasuonno; Robert A Colbert; Anna Colell; Miodrag Čolić; Nuria S Coll; Mark O Collins; María I Colombo; Daniel A Colón-Ramos; Lydie Combaret; Sergio Comincini; Márcia R Cominetti; Antonella Consiglio; Andrea Conte; Fabrizio Conti; Viorica Raluca Contu; Mark R Cookson; Kevin M Coombs; Isabelle Coppens; Maria Tiziana Corasaniti; Dale P Corkery; Nils Cordes; Katia Cortese; Maria do Carmo Costa; Sarah Costantino; Paola Costelli; Ana Coto-Montes; Peter J Crack; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Riccardo Cristofani; Tamas Csizmadia; Antonio Cuadrado; Bing Cui; Jun Cui; Yixian Cui; Yong Cui; Emmanuel Culetto; Andrea C Cumino; Andrey V Cybulsky; Mark J Czaja; Stanislaw J Czuczwar; Stefania D'Adamo; Marcello D'Amelio; Daniela D'Arcangelo; Andrew C D'Lugos; Gabriella D'Orazi; James A da Silva; Hormos Salimi Dafsari; Ruben K Dagda; Yasin Dagdas; Maria Daglia; Xiaoxia Dai; Yun Dai; Yuyuan Dai; Jessica Dal Col; Paul Dalhaimer; Luisa Dalla Valle; Tobias Dallenga; Guillaume Dalmasso; Markus Damme; Ilaria Dando; Nico P Dantuma; April L Darling; Hiranmoy Das; Srinivasan Dasarathy; Santosh K Dasari; Srikanta Dash; Oliver Daumke; Adrian N Dauphinee; Jeffrey S Davies; Valeria A Dávila; Roger J Davis; Tanja Davis; Sharadha Dayalan Naidu; Francesca De Amicis; Karolien De Bosscher; Francesca De Felice; Lucia De Franceschi; Chiara De Leonibus; Mayara G de Mattos Barbosa; Guido R Y De Meyer; Angelo De Milito; Cosimo De Nunzio; Clara De Palma; Mauro De Santi; Claudio De Virgilio; Daniela De Zio; Jayanta Debnath; Brian J DeBosch; Jean-Paul Decuypere; Mark A Deehan; Gianluca Deflorian; James DeGregori; Benjamin Dehay; Gabriel Del Rio; Joe R Delaney; Lea M D Delbridge; Elizabeth Delorme-Axford; M Victoria Delpino; Francesca Demarchi; Vilma Dembitz; Nicholas D Demers; Hongbin Deng; Zhiqiang Deng; Joern Dengjel; Paul Dent; Donna Denton; Melvin L DePamphilis; Channing J Der; Vojo Deretic; Albert Descoteaux; Laura Devis; Sushil Devkota; Olivier Devuyst; Grant Dewson; Mahendiran Dharmasivam; Rohan Dhiman; Diego di Bernardo; Manlio Di Cristina; Fabio Di Domenico; Pietro Di Fazio; Alessio Di Fonzo; Giovanni Di Guardo; Gianni M Di Guglielmo; Luca Di Leo; Chiara Di Malta; Alessia Di Nardo; Martina Di Rienzo; Federica Di Sano; George Diallinas; Jiajie Diao; Guillermo Diaz-Araya; Inés Díaz-Laviada; Jared M Dickinson; Marc Diederich; Mélanie Dieudé; Ivan Dikic; Shiping Ding; Wen-Xing Ding; Luciana Dini; Jelena Dinić; Miroslav Dinic; Albena T Dinkova-Kostova; Marc S Dionne; Jörg H W Distler; Abhinav Diwan; Ian M C Dixon; Mojgan Djavaheri-Mergny; Ina Dobrinski; Oxana Dobrovinskaya; Radek Dobrowolski; Renwick C J Dobson; Jelena Đokić; Serap Dokmeci Emre; Massimo Donadelli; Bo Dong; Xiaonan Dong; Zhiwu Dong; Gerald W Dorn Ii; Volker Dotsch; Huan Dou; Juan Dou; Moataz Dowaidar; Sami Dridi; Liat Drucker; Ailian Du; Caigan Du; Guangwei Du; Hai-Ning Du; Li-Lin Du; André du Toit; Shao-Bin Duan; Xiaoqiong Duan; Sónia P Duarte; Anna Dubrovska; Elaine A Dunlop; Nicolas Dupont; Raúl V Durán; Bilikere S Dwarakanath; Sergey A Dyshlovoy; Darius Ebrahimi-Fakhari; Leopold Eckhart; Charles L Edelstein; Thomas Efferth; Eftekhar Eftekharpour; Ludwig Eichinger; Nabil Eid; Tobias Eisenberg; N Tony Eissa; Sanaa Eissa; Miriam Ejarque; Abdeljabar El Andaloussi; Nazira El-Hage; Shahenda El-Naggar; Anna Maria Eleuteri; Eman S El-Shafey; Mohamed Elgendy; Aristides G Eliopoulos; María M Elizalde; Philip M Elks; Hans-Peter Elsasser; Eslam S Elsherbiny; Brooke M Emerling; N C Tolga Emre; Christina H Eng; Nikolai Engedal; Anna-Mart Engelbrecht; Agnete S T Engelsen; Jorrit M Enserink; Ricardo Escalante; Audrey Esclatine; Mafalda Escobar-Henriques; Eeva-Liisa Eskelinen; Lucile Espert; Makandjou-Ola Eusebio; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Francesco Facchiano; Bengt Fadeel; Claudio Fader; Alex C Faesen; W Douglas Fairlie; Alberto Falcó; Bjorn H Falkenburger; Daping Fan; Jie Fan; Yanbo Fan; Evandro F Fang; Yanshan Fang; Yognqi Fang; Manolis Fanto; Tamar Farfel-Becker; Mathias Faure; Gholamreza Fazeli; Anthony O Fedele; Arthur M Feldman; Du Feng; Jiachun Feng; Lifeng Feng; Yibin Feng; Yuchen Feng; Wei Feng; Thais Fenz Araujo; Thomas A Ferguson; Álvaro F Fernández; Jose C Fernandez-Checa; Sonia Fernández-Veledo; Alisdair R Fernie; Anthony W Ferrante; Alessandra Ferraresi; Merari F Ferrari; Julio C B Ferreira; Susan Ferro-Novick; Antonio Figueras; Riccardo Filadi; Nicoletta Filigheddu; Eduardo Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; Vittorio Fineschi; Francesca Finetti; Steven Finkbeiner; Edward A Fisher; Paul B Fisher; Flavio Flamigni; Steven J Fliesler; Trude H Flo; Ida Florance; Oliver Florey; Tullio Florio; Erika Fodor; Carlo Follo; Edward A Fon; Antonella Forlino; Francesco Fornai; Paola Fortini; Anna Fracassi; Alessandro Fraldi; Brunella Franco; Rodrigo Franco; Flavia Franconi; Lisa B Frankel; Scott L Friedman; Leopold F Fröhlich; Gema Frühbeck; Jose M Fuentes; Yukio Fujiki; Naonobu Fujita; Yuuki Fujiwara; Mitsunori Fukuda; Simone Fulda; Luc Furic; Norihiko Furuya; Carmela Fusco; Michaela U Gack; Lidia Gaffke; Sehamuddin Galadari; Alessia Galasso; Maria F Galindo; Sachith Gallolu Kankanamalage; Lorenzo Galluzzi; Vincent Galy; Noor Gammoh; Boyi Gan; Ian G Ganley; Feng Gao; Hui Gao; Minghui Gao; Ping Gao; Shou-Jiang Gao; Wentao Gao; Xiaobo Gao; Ana Garcera; Maria Noé Garcia; Verónica E Garcia; Francisco García-Del Portillo; Vega Garcia-Escudero; Aracely Garcia-Garcia; Marina Garcia-Macia; Diana García-Moreno; Carmen Garcia-Ruiz; Patricia García-Sanz; Abhishek D Garg; Ricardo Gargini; Tina Garofalo; Robert F Garry; Nils C Gassen; Damian Gatica; Liang Ge; Wanzhong Ge; Ruth Geiss-Friedlander; Cecilia Gelfi; Pascal Genschik; Ian E Gentle; Valeria Gerbino; Christoph Gerhardt; Kyla Germain; Marc Germain; David A Gewirtz; Elham Ghasemipour Afshar; Saeid Ghavami; Alessandra Ghigo; Manosij Ghosh; Georgios Giamas; Claudia Giampietri; Alexandra Giatromanolaki; Gary E Gibson; Spencer B Gibson; Vanessa Ginet; Edward Giniger; Carlotta Giorgi; Henrique Girao; Stephen E Girardin; Mridhula Giridharan; Sandy Giuliano; Cecilia Giulivi; Sylvie Giuriato; Julien Giustiniani; Alexander Gluschko; Veit Goder; Alexander Goginashvili; Jakub Golab; David C Goldstone; Anna Golebiewska; Luciana R Gomes; Rodrigo Gomez; Rubén Gómez-Sánchez; Maria Catalina Gomez-Puerto; Raquel Gomez-Sintes; Qingqiu Gong; Felix M Goni; Javier González-Gallego; Tomas Gonzalez-Hernandez; Rosa A Gonzalez-Polo; Jose A Gonzalez-Reyes; Patricia González-Rodríguez; Ing Swie Goping; Marina S Gorbatyuk; Nikolai V Gorbunov; Kıvanç Görgülü; Roxana M Gorojod; Sharon M Gorski; Sandro Goruppi; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Martin Graef; Markus H Gräler; Veronica Granatiero; Daniel Grasso; Joshua P Gray; Douglas R Green; Alexander Greenhough; Stephen L Gregory; Edward F Griffin; Mark W Grinstaff; Frederic Gros; Charles Grose; Angelina S Gross; Florian Gruber; Paolo Grumati; Tilman Grune; Xueyan Gu; Jun-Lin Guan; Carlos M Guardia; Kishore Guda; Flora Guerra; Consuelo Guerri; Prasun Guha; Carlos Guillén; Shashi Gujar; Anna Gukovskaya; Ilya Gukovsky; Jan Gunst; Andreas Günther; Anyonya R Guntur; Chuanyong Guo; Chun Guo; Hongqing Guo; Lian-Wang Guo; Ming Guo; Pawan Gupta; Shashi Kumar Gupta; Swapnil Gupta; Veer Bala Gupta; Vivek Gupta; Asa B Gustafsson; David D Gutterman; Ranjitha H B; Annakaisa Haapasalo; James E Haber; Aleksandra Hać; Shinji Hadano; Anders J Hafrén; Mansour Haidar; Belinda S Hall; Gunnel Halldén; Anne Hamacher-Brady; Andrea Hamann; Maho Hamasaki; Weidong Han; Malene Hansen; Phyllis I Hanson; Zijian Hao; Masaru Harada; Ljubica Harhaji-Trajkovic; Nirmala Hariharan; Nigil Haroon; James Harris; Takafumi Hasegawa; Noor Hasima Nagoor; Jeffrey A Haspel; Volker Haucke; Wayne D Hawkins; Bruce A Hay; Cole M Haynes; Soren B Hayrabedyan; Thomas S Hays; Congcong He; Qin He; Rong-Rong He; You-Wen He; Yu-Ying He; Yasser Heakal; Alexander M Heberle; J Fielding Hejtmancik; Gudmundur Vignir Helgason; Vanessa Henkel; Marc Herb; Alexander Hergovich; Anna Herman-Antosiewicz; Agustín Hernández; Carlos Hernandez; Sergio Hernandez-Diaz; Virginia Hernandez-Gea; Amaury Herpin; Judit Herreros; Javier H Hervás; Daniel Hesselson; Claudio Hetz; Volker T Heussler; Yujiro Higuchi; Sabine Hilfiker; Joseph A Hill; William S Hlavacek; Emmanuel A Ho; Idy H T Ho; Philip Wing-Lok Ho; Shu-Leong Ho; Wan Yun Ho; G Aaron Hobbs; Mark Hochstrasser; Peter H M Hoet; Daniel Hofius; Paul Hofman; Annika Höhn; Carina I Holmberg; Jose R Hombrebueno; Chang-Won Hong Yi-Ren Hong; Lora V Hooper; Thorsten Hoppe; Rastislav Horos; Yujin Hoshida; I-Lun Hsin; Hsin-Yun Hsu; Bing Hu; Dong Hu; Li-Fang Hu; Ming Chang Hu; Ronggui Hu; Wei Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Jinlian Hua; Yingqi Hua; Chongmin Huan; Canhua Huang; Chuanshu Huang; Chuanxin Huang; Chunling Huang; Haishan Huang; Kun Huang; Michael L H Huang; Rui Huang; Shan Huang; Tianzhi Huang; Xing Huang; Yuxiang Jack Huang; Tobias B Huber; Virginie Hubert; Christian A Hubner; Stephanie M Hughes; William E Hughes; Magali Humbert; Gerhard Hummer; James H Hurley; Sabah Hussain; Salik Hussain; Patrick J Hussey; Martina Hutabarat; Hui-Yun Hwang; Seungmin Hwang; Antonio Ieni; Fumiyo Ikeda; Yusuke Imagawa; Yuzuru Imai; Carol Imbriano; Masaya Imoto; Denise M Inman; Ken Inoki; Juan Iovanna; Renato V Iozzo; Giuseppe Ippolito; Javier E Irazoqui; Pablo Iribarren; Mohd Ishaq; Makoto Ishikawa; Nestor Ishimwe; Ciro Isidoro; Nahed Ismail; Shohreh Issazadeh-Navikas; Eisuke Itakura; Daisuke Ito; Davor Ivankovic; Saška Ivanova; Anand Krishnan V Iyer; José M Izquierdo; Masanori Izumi; Marja Jäättelä; Majid Sakhi Jabir; William T Jackson; Nadia Jacobo-Herrera; Anne-Claire Jacomin; Elise Jacquin; Pooja Jadiya; Hartmut Jaeschke; Chinnaswamy Jagannath; Arjen J Jakobi; Johan Jakobsson; Bassam Janji; Pidder Jansen-Dürr; Patric J Jansson; Jonathan Jantsch; Sławomir Januszewski; Alagie Jassey; Steve Jean; Hélène Jeltsch-David; Pavla Jendelova; Andreas Jenny; Thomas E Jensen; Niels Jessen; Jenna L Jewell; Jing Ji; Lijun Jia; Rui Jia; Liwen Jiang; Qing Jiang; Richeng Jiang; Teng Jiang; Xuejun Jiang; Yu Jiang; Maria Jimenez-Sanchez; Eun-Jung Jin; Fengyan Jin; Hongchuan Jin; Li Jin; Luqi Jin; Meiyan Jin; Si Jin; Eun-Kyeong Jo; Carine Joffre; Terje Johansen; Gail V W Johnson; Simon A Johnston; Eija Jokitalo; Mohit Kumar Jolly; Leo A B Joosten; Joaquin Jordan; Bertrand Joseph; Dianwen Ju; Jeong-Sun Ju; Jingfang Ju; Esmeralda Juárez; Delphine Judith; Gábor Juhász; Youngsoo Jun; Chang Hwa Jung; Sung-Chul Jung; Yong Keun Jung; Heinz Jungbluth; Johannes Jungverdorben; Steffen Just; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Daniel Kaganovich; Alon Kahana; Renate Kain; Shinjo Kajimura; Maria Kalamvoki; Manjula Kalia; Danuta S Kalinowski; Nina Kaludercic; Ioanna Kalvari; Joanna Kaminska; Vitaliy O Kaminskyy; Hiromitsu Kanamori; Keizo Kanasaki; Chanhee Kang; Rui Kang; Sang Sun Kang; Senthilvelrajan Kaniyappan; Tomotake Kanki; Thirumala-Devi Kanneganti; Anumantha G Kanthasamy; Arthi Kanthasamy; Marc Kantorow; Orsolya Kapuy; Michalis V Karamouzis; Md Razaul Karim; Parimal Karmakar; Rajesh G Katare; Masaru Kato; Stefan H E Kaufmann; Anu Kauppinen; Gur P Kaushal; Susmita Kaushik; Kiyoshi Kawasaki; Kemal Kazan; Po-Yuan Ke; Damien J Keating; Ursula Keber; John H Kehrl; Kate E Keller; Christian W Keller; Jongsook Kim Kemper; Candia M Kenific; Oliver Kepp; Stephanie Kermorgant; Andreas Kern; Robin Ketteler; Tom G Keulers; Boris Khalfin; Hany Khalil; Bilon Khambu; Shahid Y Khan; Vinoth Kumar Megraj Khandelwal; Rekha Khandia; Widuri Kho; Noopur V Khobrekar; Sataree Khuansuwan; Mukhran Khundadze; Samuel A Killackey; Dasol Kim; Deok Ryong Kim; Do-Hyung Kim; Dong-Eun Kim; Eun Young Kim; Eun-Kyoung Kim; Hak-Rim Kim; Hee-Sik Kim; Jeong Hun Kim; Jin Kyung Kim; Jin-Hoi Kim; Joungmok Kim; Ju Hwan Kim; Keun Il Kim; Peter K Kim; Seong-Jun Kim; Scot R Kimball; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Matthew A King; Kerri J Kinghorn; Conan G Kinsey; Vladimir Kirkin; Lorrie A Kirshenbaum; Sergey L Kiselev; Shuji Kishi; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Richard N Kitsis; Josef T Kittler; Ole Kjaerulff; Peter S Klein; Thomas Klopstock; Jochen Klucken; Helene Knævelsrud; Roland L Knorr; Ben C B Ko; Fred Ko; Jiunn-Liang Ko; Hotaka Kobayashi; Satoru Kobayashi; Ina Koch; Jan C Koch; Ulrich Koenig; Donat Kögel; Young Ho Koh; Masato Koike; Sepp D Kohlwein; Nur M Kocaturk; Masaaki Komatsu; Jeannette König; Toru Kono; Benjamin T Kopp; Tamas Korcsmaros; Gözde Korkmaz; Viktor I Korolchuk; Mónica Suárez Korsnes; Ali Koskela; Janaiah Kota; Yaichiro Kotake; Monica L Kotler; Yanjun Kou; Michael I Koukourakis; Evangelos Koustas; Attila L Kovacs; Tibor Kovács; Daisuke Koya; Tomohiro Kozako; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Anna D Krasnodembskaya; Carole Kretz-Remy; Guido Kroemer; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Sabine Kuenen; Lars Kuerschner; Thomas Kukar; Ajay Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Sharad Kumar; Shinji Kume; Caroline Kumsta; Chanakya N Kundu; Mondira Kundu; Ajaikumar B Kunnumakkara; Lukasz Kurgan; Tatiana G Kutateladze; Ozlem Kutlu; SeongAe Kwak; Ho Jeong Kwon; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert La Spada; Patrick Labonté; Sylvain Ladoire; Ilaria Laface; Frank Lafont; Diane C Lagace; Vikramjit Lahiri; Zhibing Lai; Angela S Laird; Aparna Lakkaraju; Trond Lamark; Sheng-Hui Lan; Ane Landajuela; Darius J R Lane; Jon D Lane; Charles H Lang; Carsten Lange; Ülo Langel; Rupert Langer; Pierre Lapaquette; Jocelyn Laporte; Nicholas F LaRusso; Isabel Lastres-Becker; Wilson Chun Yu Lau; Gordon W Laurie; Sergio Lavandero; Betty Yuen Kwan Law; Helen Ka-Wai Law; Rob Layfield; Weidong Le; Herve Le Stunff; Alexandre Y Leary; Jean-Jacques Lebrun; Lionel Y W Leck; Jean-Philippe Leduc-Gaudet; Changwook Lee; Chung-Pei Lee; Da-Hye Lee; Edward B Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Heung Kyu Lee; Jae Man Lee; Jason S Lee; Jin-A Lee; Joo-Yong Lee; Jun Hee Lee; Michael Lee; Min Goo Lee; Min Jae Lee; Myung-Shik Lee; Sang Yoon Lee; Seung-Jae Lee; Stella Y Lee; Sung Bae Lee; Won Hee Lee; Ying-Ray Lee; Yong-Ho Lee; Youngil Lee; Christophe Lefebvre; Renaud Legouis; Yu L Lei; Yuchen Lei; Sergey Leikin; Gerd Leitinger; Leticia Lemus; Shuilong Leng; Olivia Lenoir; Guido Lenz; Heinz Josef Lenz; Paola Lenzi; Yolanda León; Andréia M Leopoldino; Christoph Leschczyk; Stina Leskelä; Elisabeth Letellier; Chi-Ting Leung; Po Sing Leung; Jeremy S Leventhal; Beth Levine; Patrick A Lewis; Klaus Ley; Bin Li; Da-Qiang Li; Jianming Li; Jing Li; Jiong Li; Ke Li; Liwu Li; Mei Li; Min Li; Min Li; Ming Li; Mingchuan Li; Pin-Lan Li; Ming-Qing Li; Qing Li; Sheng Li; Tiangang Li; Wei Li; Wenming Li; Xue Li; Yi-Ping Li; Yuan Li; Zhiqiang Li; Zhiyong Li; Zhiyuan Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Weicheng Liang; Yongheng Liang; YongTian Liang; Guanghong Liao; Lujian Liao; Mingzhi Liao; Yung-Feng Liao; Mariangela Librizzi; Pearl P Y Lie; Mary A Lilly; Hyunjung J Lim; Thania R R Lima; Federica Limana; Chao Lin; Chih-Wen Lin; Dar-Shong Lin; Fu-Cheng Lin; Jiandie D Lin; Kurt M Lin; Kwang-Huei Lin; Liang-Tzung Lin; Pei-Hui Lin; Qiong Lin; Shaofeng Lin; Su-Ju Lin; Wenyu Lin; Xueying Lin; Yao-Xin Lin; Yee-Shin Lin; Rafael Linden; Paula Lindner; Shuo-Chien Ling; Paul Lingor; Amelia K Linnemann; Yih-Cherng Liou; Marta M Lipinski; Saška Lipovšek; Vitor A Lira; Natalia Lisiak; Paloma B Liton; Chao Liu; Ching-Hsuan Liu; Chun-Feng Liu; Cui Hua Liu; Fang Liu; Hao Liu; Hsiao-Sheng Liu; Hua-Feng Liu; Huifang Liu; Jia Liu; Jing Liu; Julia Liu; Leyuan Liu; Longhua Liu; Meilian Liu; Qin Liu; Wei Liu; Wende Liu; Xiao-Hong Liu; Xiaodong Liu; Xingguo Liu; Xu Liu; Xuedong Liu; Yanfen Liu; Yang Liu; Yang Liu; Yueyang Liu; Yule Liu; J Andrew Livingston; Gerard Lizard; Jose M Lizcano; Senka Ljubojevic-Holzer; Matilde E LLeonart; David Llobet-Navàs; Alicia Llorente; Chih Hung Lo; Damián Lobato-Márquez; Qi Long; Yun Chau Long; Ben Loos; Julia A Loos; Manuela G López; Guillermo López-Doménech; José Antonio López-Guerrero; Ana T López-Jiménez; Óscar López-Pérez; Israel López-Valero; Magdalena J Lorenowicz; Mar Lorente; Peter Lorincz; Laura Lossi; Sophie Lotersztajn; Penny E Lovat; Jonathan F Lovell; Alenka Lovy; Péter Lőw; Guang Lu; Haocheng Lu; Jia-Hong Lu; Jin-Jian Lu; Mengji Lu; Shuyan Lu; Alessandro Luciani; John M Lucocq; Paula Ludovico; Micah A Luftig; Morten Luhr; Diego Luis-Ravelo; Julian J Lum; Liany Luna-Dulcey; Anders H Lund; Viktor K Lund; Jan D Lünemann; Patrick Lüningschrör; Honglin Luo; Rongcan Luo; Shouqing Luo; Zhi Luo; Claudio Luparello; Bernhard Lüscher; Luan Luu; Alex Lyakhovich; Konstantin G Lyamzaev; Alf Håkon Lystad; Lyubomyr Lytvynchuk; Alvin C Ma; Changle Ma; Mengxiao Ma; Ning-Fang Ma; Quan-Hong Ma; Xinliang Ma; Yueyun Ma; Zhenyi Ma; Ormond A MacDougald; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; Sandra Maday; Frank Madeo; Muniswamy Madesh; Tobias Madl; Julio Madrigal-Matute; Akiko Maeda; Yasuhiro Maejima; Marta Magarinos; Poornima Mahavadi; Emiliano Maiani; Kenneth Maiese; Panchanan Maiti; Maria Chiara Maiuri; Barbara Majello; Michael B Major; Elena Makareeva; Fayaz Malik; Karthik Mallilankaraman; Walter Malorni; Alina Maloyan; Najiba Mammadova; Gene Chi Wai Man; Federico Manai; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Masoud H Manjili; Ravi Manjithaya; Patricio Manque; Bella B Manshian; Raquel Manzano; Claudia Manzoni; Kai Mao; Cinzia Marchese; Sandrine Marchetti; Anna Maria Marconi; Fabrizio Marcucci; Stefania Mardente; Olga A Mareninova; Marta Margeta; Muriel Mari; Sara Marinelli; Oliviero Marinelli; Guillermo Mariño; Sofia Mariotto; Richard S Marshall; Mark R Marten; Sascha Martens; Alexandre P J Martin; Katie R Martin; Sara Martin; Shaun Martin; Adrián Martín-Segura; Miguel A Martín-Acebes; Inmaculada Martin-Burriel; Marcos Martin-Rincon; Paloma Martin-Sanz; José A Martina; Wim Martinet; Aitor Martinez; Ana Martinez; Jennifer Martinez; Moises Martinez Velazquez; Nuria Martinez-Lopez; Marta Martinez-Vicente; Daniel O Martins; Joilson O Martins; Waleska K Martins; Tania Martins-Marques; Emanuele Marzetti; Shashank Masaldan; Celine Masclaux-Daubresse; Douglas G Mashek; Valentina Massa; Lourdes Massieu; Glenn R Masson; Laura Masuelli; Anatoliy I Masyuk; Tetyana V Masyuk; Paola Matarrese; Ander Matheu; Satoaki Matoba; Sachiko Matsuzaki; Pamela Mattar; Alessandro Matte; Domenico Mattoscio; José L Mauriz; Mario Mauthe; Caroline Mauvezin; Emanual Maverakis; Paola Maycotte; Johanna Mayer; Gianluigi Mazzoccoli; Cristina Mazzoni; Joseph R Mazzulli; Nami McCarty; Christine McDonald; Mitchell R McGill; Sharon L McKenna; BethAnn McLaughlin; Fionn McLoughlin; Mark A McNiven; Thomas G McWilliams; Fatima Mechta-Grigoriou; Tania Catarina Medeiros; Diego L Medina; Lynn A Megeney; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Alfred J Meijer; Annemarie H Meijer; Jakob Mejlvang; Alicia Meléndez; Annette Melk; Gonen Memisoglu; Alexandrina F Mendes; Delong Meng; Fei Meng; Tian Meng; Rubem Menna-Barreto; Manoj B Menon; Carol Mercer; Anne E Mercier; Jean-Louis Mergny; Adalberto Merighi; Seth D Merkley; Giuseppe Merla; Volker Meske; Ana Cecilia Mestre; Shree Padma Metur; Christian Meyer; Hemmo Meyer; Wenyi Mi; Jeanne Mialet-Perez; Junying Miao; Lucia Micale; Yasuo Miki; Enrico Milan; Małgorzata Milczarek; Dana L Miller; Samuel I Miller; Silke Miller; Steven W Millward; Ira Milosevic; Elena A Minina; Hamed Mirzaei; Hamid Reza Mirzaei; Mehdi Mirzaei; Amit Mishra; Nandita Mishra; Paras Kumar Mishra; Maja Misirkic Marjanovic; Roberta Misasi; Amit Misra; Gabriella Misso; Claire Mitchell; Geraldine Mitou; Tetsuji Miura; Shigeki Miyamoto; Makoto Miyazaki; Mitsunori Miyazaki; Taiga Miyazaki; Keisuke Miyazawa; Noboru Mizushima; Trine H Mogensen; Baharia Mograbi; Reza Mohammadinejad; Yasir Mohamud; Abhishek Mohanty; Sipra Mohapatra; Torsten Möhlmann; Asif Mohmmed; Anna Moles; Kelle H Moley; Maurizio Molinari; Vincenzo Mollace; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Costanza Montagna; Mervyn J Monteiro; Andrea Montella; L Ruth Montes; Barbara Montico; Vinod K Mony; Giacomo Monzio Compagnoni; Michael N Moore; Mohammad A Moosavi; Ana L Mora; Marina Mora; David Morales-Alamo; Rosario Moratalla; Paula I Moreira; Elena Morelli; Sandra Moreno; Daniel Moreno-Blas; Viviana Moresi; Benjamin Morga; Alwena H Morgan; Fabrice Morin; Hideaki Morishita; Orson L Moritz; Mariko Moriyama; Yuji Moriyasu; Manuela Morleo; Eugenia Morselli; Jose F Moruno-Manchon; Jorge Moscat; Serge Mostowy; Elisa Motori; Andrea Felinto Moura; Naima Moustaid-Moussa; Maria Mrakovcic; Gabriel Muciño-Hernández; Anupam Mukherjee; Subhadip Mukhopadhyay; Jean M Mulcahy Levy; Victoriano Mulero; Sylviane Muller; Christian Münch; Ashok Munjal; Pura Munoz-Canoves; Teresa Muñoz-Galdeano; Christian Münz; Tomokazu Murakawa; Claudia Muratori; Brona M Murphy; J Patrick Murphy; Aditya Murthy; Timo T Myöhänen; Indira U Mysorekar; Jennifer Mytych; Seyed Mohammad Nabavi; Massimo Nabissi; Péter Nagy; Jihoon Nah; Aimable Nahimana; Ichiro Nakagawa; Ken Nakamura; Hitoshi Nakatogawa; Shyam S Nandi; Meera Nanjundan; Monica Nanni; Gennaro Napolitano; Roberta Nardacci; Masashi Narita; Melissa Nassif; Ilana Nathan; Manabu Natsumeda; Ryno J Naude; Christin Naumann; Olaia Naveiras; Fatemeh Navid; Steffan T Nawrocki; Taras Y Nazarko; Francesca Nazio; Florentina Negoita; Thomas Neill; Amanda L Neisch; Luca M Neri; Mihai G Netea; Patrick Neubert; Thomas P Neufeld; Dietbert Neumann; Albert Neutzner; Phillip T Newton; Paul A Ney; Ioannis P Nezis; Charlene C W Ng; Tzi Bun Ng; Hang T T Nguyen; Long T Nguyen; Hong-Min Ni; Clíona Ní Cheallaigh; Zhenhong Ni; M Celeste Nicolao; Francesco Nicoli; Manuel Nieto-Diaz; Per Nilsson; Shunbin Ning; Rituraj Niranjan; Hiroshi Nishimune; Mireia Niso-Santano; Ralph A Nixon; Annalisa Nobili; Clevio Nobrega; Takeshi Noda; Uxía Nogueira-Recalde; Trevor M Nolan; Ivan Nombela; Ivana Novak; Beatriz Novoa; Takashi Nozawa; Nobuyuki Nukina; Carmen Nussbaum-Krammer; Jesper Nylandsted; Tracey R O'Donovan; Seónadh M O'Leary; Eyleen J O'Rourke; Mary P O'Sullivan; Timothy E O'Sullivan; Salvatore Oddo; Ina Oehme; Michinaga Ogawa; Eric Ogier-Denis; Margret H Ogmundsdottir; Besim Ogretmen; Goo Taeg Oh; Seon-Hee Oh; Young J Oh; Takashi Ohama; Yohei Ohashi; Masaki Ohmuraya; Vasileios Oikonomou; Rani Ojha; Koji Okamoto; Hitoshi Okazawa; Masahide Oku; Sara Oliván; Jorge M A Oliveira; Michael Ollmann; James A Olzmann; Shakib Omari; M Bishr Omary; Gizem Önal; Martin Ondrej; Sang-Bing Ong; Sang-Ging Ong; Anna Onnis; Juan A Orellana; Sara Orellana-Muñoz; Maria Del Mar Ortega-Villaizan; Xilma R Ortiz-Gonzalez; Elena Ortona; Heinz D Osiewacz; Abdel-Hamid K Osman; Rosario Osta; Marisa S Otegui; Kinya Otsu; Christiane Ott; Luisa Ottobrini; Jing-Hsiung James Ou; Tiago F Outeiro; Inger Oynebraten; Melek Ozturk; Gilles Pagès; Susanta Pahari; Marta Pajares; Utpal B Pajvani; Rituraj Pal; Simona Paladino; Nicolas Pallet; Michela Palmieri; Giuseppe Palmisano; Camilla Palumbo; Francesco Pampaloni; Lifeng Pan; Qingjun Pan; Wenliang Pan; Xin Pan; Ganna Panasyuk; Rahul Pandey; Udai B Pandey; Vrajesh Pandya; Francesco Paneni; Shirley Y Pang; Elisa Panzarini; Daniela L Papademetrio; Elena Papaleo; Daniel Papinski; Diana Papp; Eun Chan Park; Hwan Tae Park; Ji-Man Park; Jong-In Park; Joon Tae Park; Junsoo Park; Sang Chul Park; Sang-Youel Park; Abraham H Parola; Jan B Parys; Adrien Pasquier; Benoit Pasquier; João F Passos; Nunzia Pastore; Hemal H Patel; Daniel Patschan; Sophie Pattingre; Gustavo Pedraza-Alva; Jose Pedraza-Chaverri; Zully Pedrozo; Gang Pei; Jianming Pei; Hadas Peled-Zehavi; Joaquín M Pellegrini; Joffrey Pelletier; Miguel A Peñalva; Di Peng; Ying Peng; Fabio Penna; Maria Pennuto; Francesca Pentimalli; Cláudia Mf Pereira; Gustavo J S Pereira; Lilian C Pereira; Luis Pereira de Almeida; Nirma D Perera; Ángel Pérez-Lara; Ana B Perez-Oliva; María Esther Pérez-Pérez; Palsamy Periyasamy; Andras Perl; Cristiana Perrotta; Ida Perrotta; Richard G Pestell; Morten Petersen; Irina Petrache; Goran Petrovski; Thorsten Pfirrmann; Astrid S Pfister; Jennifer A Philips; Huifeng Pi; Anna Picca; Alicia M Pickrell; Sandy Picot; Giovanna M Pierantoni; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Karolina Pierzynowska; Federico Pietrocola; Miroslawa Pietruczuk; Claudio Pignata; Felipe X Pimentel-Muiños; Mario Pinar; Roberta O Pinheiro; Ronit Pinkas-Kramarski; Paolo Pinton; Karolina Pircs; Sujan Piya; Paola Pizzo; Theo S Plantinga; Harald W Platta; Ainhoa Plaza-Zabala; Markus Plomann; Egor Y Plotnikov; Helene Plun-Favreau; Ryszard Pluta; Roger Pocock; Stefanie Pöggeler; Christian Pohl; Marc Poirot; Angelo Poletti; Marisa Ponpuak; Hana Popelka; Blagovesta Popova; Helena Porta; Soledad Porte Alcon; Eliana Portilla-Fernandez; Martin Post; Malia B Potts; Joanna Poulton; Ted Powers; Veena Prahlad; Tomasz K Prajsnar; Domenico Praticò; Rosaria Prencipe; Muriel Priault; Tassula Proikas-Cezanne; Vasilis J Promponas; Christopher G Proud; Rosa Puertollano; Luigi Puglielli; Thomas Pulinilkunnil; Deepika Puri; Rajat Puri; Julien Puyal; Xiaopeng Qi; Yongmei Qi; Wenbin Qian; Lei Qiang; Yu Qiu; Joe Quadrilatero; Jorge Quarleri; Nina Raben; Hannah Rabinowich; Debora Ragona; Michael J Ragusa; Nader Rahimi; Marveh Rahmati; Valeria Raia; Nuno Raimundo; Namakkal-Soorappan Rajasekaran; Sriganesh Ramachandra Rao; Abdelhaq Rami; Ignacio Ramírez-Pardo; David B Ramsden; Felix Randow; Pundi N Rangarajan; Danilo Ranieri; Hai Rao; Lang Rao; Rekha Rao; Sumit Rathore; J Arjuna Ratnayaka; Edward A Ratovitski; Palaniyandi Ravanan; Gloria Ravegnini; Swapan K Ray; Babak Razani; Vito Rebecca; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; David Reigada; Jan H Reiling; Theo Rein; Siegfried Reipert; Rokeya Sultana Rekha; Hongmei Ren; Jun Ren; Weichao Ren; Tristan Renault; Giorgia Renga; Karen Reue; Kim Rewitz; Bruna Ribeiro de Andrade Ramos; S Amer Riazuddin; Teresa M Ribeiro-Rodrigues; Jean-Ehrland Ricci; Romeo Ricci; Victoria Riccio; Des R Richardson; Yasuko Rikihisa; Makarand V Risbud; Ruth M Risueño; Konstantinos Ritis; Salvatore Rizza; Rosario Rizzuto; Helen C Roberts; Luke D Roberts; Katherine J Robinson; Maria Carmela Roccheri; Stephane Rocchi; George G Rodney; Tiago Rodrigues; Vagner Ramon Rodrigues Silva; Amaia Rodriguez; Ruth Rodriguez-Barrueco; Nieves Rodriguez-Henche; Humberto Rodriguez-Rocha; Jeroen Roelofs; Robert S Rogers; Vladimir V Rogov; Ana I Rojo; Krzysztof Rolka; Vanina Romanello; Luigina Romani; Alessandra Romano; Patricia S Romano; David Romeo-Guitart; Luis C Romero; Montserrat Romero; Joseph C Roney; Christopher Rongo; Sante Roperto; Mathias T Rosenfeldt; Philip Rosenstiel; Anne G Rosenwald; Kevin A Roth; Lynn Roth; Steven Roth; Kasper M A Rouschop; Benoit D Roussel; Sophie Roux; Patrizia Rovere-Querini; Ajit Roy; Aurore Rozieres; Diego Ruano; David C Rubinsztein; Maria P Rubtsova; Klaus Ruckdeschel; Christoph Ruckenstuhl; Emil Rudolf; Rüdiger Rudolf; Alessandra Ruggieri; Avnika Ashok Ruparelia; Paola Rusmini; Ryan R Russell; Gian Luigi Russo; Maria Russo; Rossella Russo; Oxana O Ryabaya; Kevin M Ryan; Kwon-Yul Ryu; Maria Sabater-Arcis; Ulka Sachdev; Michael Sacher; Carsten Sachse; Abhishek Sadhu; Junichi Sadoshima; Nathaniel Safren; Paul Saftig; Antonia P Sagona; Gaurav Sahay; Amirhossein Sahebkar; Mustafa Sahin; Ozgur Sahin; Sumit Sahni; Nayuta Saito; Shigeru Saito; Tsunenori Saito; Ryohei Sakai; Yasuyoshi Sakai; Jun-Ichi Sakamaki; Kalle Saksela; Gloria Salazar; Anna Salazar-Degracia; Ghasem H Salekdeh; Ashok K Saluja; Belém Sampaio-Marques; Maria Cecilia Sanchez; Jose A Sanchez-Alcazar; Victoria Sanchez-Vera; Vanessa Sancho-Shimizu; J Thomas Sanderson; Marco Sandri; Stefano Santaguida; Laura Santambrogio; Magda M Santana; Giorgio Santoni; Alberto Sanz; Pascual Sanz; Shweta Saran; Marco Sardiello; Timothy J Sargeant; Apurva Sarin; Chinmoy Sarkar; Sovan Sarkar; Maria-Rosa Sarrias; Surajit Sarkar; Dipanka Tanu Sarmah; Jaakko Sarparanta; Aishwarya Sathyanarayan; Ranganayaki Sathyanarayanan; K Matthew Scaglione; Francesca Scatozza; Liliana Schaefer; Zachary T Schafer; Ulrich E Schaible; Anthony H V Schapira; Michael Scharl; Hermann M Schatzl; Catherine H Schein; Wiep Scheper; David Scheuring; Maria Vittoria Schiaffino; Monica Schiappacassi; Rainer Schindl; Uwe Schlattner; Oliver Schmidt; Roland Schmitt; Stephen D Schmidt; Ingo Schmitz; Eran Schmukler; Anja Schneider; Bianca E Schneider; Romana Schober; Alejandra C Schoijet; Micah B Schott; Michael Schramm; Bernd Schröder; Kai Schuh; Christoph Schüller; Ryan J Schulze; Lea Schürmanns; Jens C Schwamborn; Melanie Schwarten; Filippo Scialo; Sebastiano Sciarretta; Melanie J Scott; Kathleen W Scotto; A Ivana Scovassi; Andrea Scrima; Aurora Scrivo; David Sebastian; Salwa Sebti; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Iban Seiliez; Ekihiro Seki; Scott B Selleck; Frank W Sellke; Joshua T Selsby; Michael Sendtner; Serif Senturk; Elena Seranova; Consolato Sergi; Ruth Serra-Moreno; Hiromi Sesaki; Carmine Settembre; Subba Rao Gangi Setty; Gianluca Sgarbi; Ou Sha; John J Shacka; Javeed A Shah; Dantong Shang; Changshun Shao; Feng Shao; Soroush Sharbati; Lisa M Sharkey; Dipali Sharma; Gaurav Sharma; Kulbhushan Sharma; Pawan Sharma; Surendra Sharma; Han-Ming Shen; Hongtao Shen; Jiangang Shen; Ming Shen; Weili Shen; Zheni Shen; Rui Sheng; Zhi Sheng; Zu-Hang Sheng; Jianjian Shi; Xiaobing Shi; Ying-Hong Shi; Kahori Shiba-Fukushima; Jeng-Jer Shieh; Yohta Shimada; Shigeomi Shimizu; Makoto Shimozawa; Takahiro Shintani; Christopher J Shoemaker; Shahla Shojaei; Ikuo Shoji; Bhupendra V Shravage; Viji Shridhar; Chih-Wen Shu; Hong-Bing Shu; Ke Shui; Arvind K Shukla; Timothy E Shutt; Valentina Sica; Aleem Siddiqui; Amanda Sierra; Virginia Sierra-Torre; Santiago Signorelli; Payel Sil; Bruno J de Andrade Silva; Johnatas D Silva; Eduardo Silva-Pavez; Sandrine Silvente-Poirot; Rachel E Simmonds; Anna Katharina Simon; Hans-Uwe Simon; Matias Simons; Anurag Singh; Lalit P Singh; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Sudha B Singh; Sunaina Singh; Surinder Pal Singh; Debasish Sinha; Rohit Anthony Sinha; Sangita Sinha; Agnieszka Sirko; Kapil Sirohi; Efthimios L Sivridis; Panagiotis Skendros; Aleksandra Skirycz; Iva Slaninová; Soraya S Smaili; Andrei Smertenko; Matthew D Smith; Stefaan J Soenen; Eun Jung Sohn; Sophia P M Sok; Giancarlo Solaini; Thierry Soldati; Scott A Soleimanpour; Rosa M Soler; Alexei Solovchenko; Jason A Somarelli; Avinash Sonawane; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Kunhua Song; Zhiyin Song; Leandro R Soria; Maurizio Sorice; Alexander A Soukas; Sandra-Fausia Soukup; Diana Sousa; Nadia Sousa; Paul A Spagnuolo; Stephen A Spector; M M Srinivas Bharath; Daret St Clair; Venturina Stagni; Leopoldo Staiano; Clint A Stalnecker; Metodi V Stankov; Peter B Stathopulos; Katja Stefan; Sven Marcel Stefan; Leonidas Stefanis; Joan S Steffan; Alexander Steinkasserer; Harald Stenmark; Jared Sterneckert; Craig Stevens; Veronika Stoka; Stephan Storch; Björn Stork; Flavie Strappazzon; Anne Marie Strohecker; Dwayne G Stupack; Huanxing Su; Ling-Yan Su; Longxiang Su; Ana M Suarez-Fontes; Carlos S Subauste; Selvakumar Subbian; Paula V Subirada; Ganapasam Sudhandiran; Carolyn M Sue; Xinbing Sui; Corey Summers; Guangchao Sun; Jun Sun; Kang Sun; Meng-Xiang Sun; Qiming Sun; Yi Sun; Zhongjie Sun; Karen K S Sunahara; Eva Sundberg; Katalin Susztak; Peter Sutovsky; Hidekazu Suzuki; Gary Sweeney; J David Symons; Stephen Cho Wing Sze; Nathaniel J Szewczyk; Anna Tabęcka-Łonczynska; Claudio Tabolacci; Frank Tacke; Heinrich Taegtmeyer; Marco Tafani; Mitsuo Tagaya; Haoran Tai; Stephen W G Tait; Yoshinori Takahashi; Szabolcs Takats; Priti Talwar; Chit Tam; Shing Yau Tam; Davide Tampellini; Atsushi Tamura; Chong Teik Tan; Eng-King Tan; Ya-Qin Tan; Masaki Tanaka; Motomasa Tanaka; Daolin Tang; Jingfeng Tang; Tie-Shan Tang; Isei Tanida; Zhipeng Tao; Mohammed Taouis; Lars Tatenhorst; Nektarios Tavernarakis; Allen Taylor; Gregory A Taylor; Joan M Taylor; Elena Tchetina; Andrew R Tee; Irmgard Tegeder; David Teis; Natercia Teixeira; Fatima Teixeira-Clerc; Kumsal A Tekirdag; Tewin Tencomnao; Sandra Tenreiro; Alexei V Tepikin; Pilar S Testillano; Gianluca Tettamanti; Pierre-Louis Tharaux; Kathrin Thedieck; Arvind A Thekkinghat; Stefano Thellung; Josephine W Thinwa; V P Thirumalaikumar; Sufi Mary Thomas; Paul G Thomes; Andrew Thorburn; Lipi Thukral; Thomas Thum; Michael Thumm; Ling Tian; Ales Tichy; Andreas Till; Vincent Timmerman; Vladimir I Titorenko; Sokol V Todi; Krassimira Todorova; Janne M Toivonen; Luana Tomaipitinca; Dhanendra Tomar; Cristina Tomas-Zapico; Sergej Tomić; Benjamin Chun-Kit Tong; Chao Tong; Xin Tong; Sharon A Tooze; Maria L Torgersen; Satoru Torii; Liliana Torres-López; Alicia Torriglia; Christina G Towers; Roberto Towns; Shinya Toyokuni; Vladimir Trajkovic; Donatella Tramontano; Quynh-Giao Tran; Leonardo H Travassos; Charles B Trelford; Shirley Tremel; Ioannis P Trougakos; Betty P Tsao; Mario P Tschan; Hung-Fat Tse; Tak Fu Tse; Hitoshi Tsugawa; Andrey S Tsvetkov; David A Tumbarello; Yasin Tumtas; María J Tuñón; Sandra Turcotte; Boris Turk; Vito Turk; Bradley J Turner; Richard I Tuxworth; Jessica K Tyler; Elena V Tyutereva; Yasuo Uchiyama; Aslihan Ugun-Klusek; Holm H Uhlig; Marzena Ułamek-Kozioł; Ilya V Ulasov; Midori Umekawa; Christian Ungermann; Rei Unno; Sylvie Urbe; Elisabet Uribe-Carretero; Suayib Üstün; Vladimir N Uversky; Thomas Vaccari; Maria I Vaccaro; Björn F Vahsen; Helin Vakifahmetoglu-Norberg; Rut Valdor; Maria J Valente; Ayelén Valko; Richard B Vallee; Angela M Valverde; Greet Van den Berghe; Stijn van der Veen; Luc Van Kaer; Jorg van Loosdregt; Sjoerd J L van Wijk; Wim Vandenberghe; Ilse Vanhorebeek; Marcos A Vannier-Santos; Nicola Vannini; M Cristina Vanrell; Chiara Vantaggiato; Gabriele Varano; Isabel Varela-Nieto; Máté Varga; M Helena Vasconcelos; Somya Vats; Demetrios G Vavvas; Ignacio Vega-Naredo; Silvia Vega-Rubin-de-Celis; Guillermo Velasco; Ariadna P Velázquez; Tibor Vellai; Edo Vellenga; Francesca Velotti; Mireille Verdier; Panayotis Verginis; Isabelle Vergne; Paul Verkade; Manish Verma; Patrik Verstreken; Tim Vervliet; Jörg Vervoorts; Alexandre T Vessoni; Victor M Victor; Michel Vidal; Chiara Vidoni; Otilia V Vieira; Richard D Vierstra; Sonia Viganó; Helena Vihinen; Vinoy Vijayan; Miquel Vila; Marçal Vilar; José M Villalba; Antonio Villalobo; Beatriz Villarejo-Zori; Francesc Villarroya; Joan Villarroya; Olivier Vincent; Cecile Vindis; Christophe Viret; Maria Teresa Viscomi; Dora Visnjic; Ilio Vitale; David J Vocadlo; Olga V Voitsekhovskaja; Cinzia Volonté; Mattia Volta; Marta Vomero; Clarissa Von Haefen; Marc A Vooijs; Wolfgang Voos; Ljubica Vucicevic; Richard Wade-Martins; Satoshi Waguri; Kenrick A Waite; Shuji Wakatsuki; David W Walker; Mark J Walker; Simon A Walker; Jochen Walter; Francisco G Wandosell; Bo Wang; Chao-Yung Wang; Chen Wang; Chenran Wang; Chenwei Wang; Cun-Yu Wang; Dong Wang; Fangyang Wang; Feng Wang; Fengming Wang; Guansong Wang; Han Wang; Hao Wang; Hexiang Wang; Hong-Gang Wang; Jianrong Wang; Jigang Wang; Jiou Wang; Jundong Wang; Kui Wang; Lianrong Wang; Liming Wang; Maggie Haitian Wang; Meiqing Wang; Nanbu Wang; Pengwei Wang; Peipei Wang; Ping Wang; Ping Wang; Qing Jun Wang; Qing Wang; Qing Kenneth Wang; Qiong A Wang; Wen-Tao Wang; Wuyang Wang; Xinnan Wang; Xuejun Wang; Yan Wang; Yanchang Wang; Yanzhuang Wang; Yen-Yun Wang; Yihua Wang; Yipeng Wang; Yu Wang; Yuqi Wang; Zhe Wang; Zhenyu Wang; Zhouguang Wang; Gary Warnes; Verena Warnsmann; Hirotaka Watada; Eizo Watanabe; Maxinne Watchon; Anna Wawrzyńska; Timothy E Weaver; Grzegorz Wegrzyn; Ann M Wehman; Huafeng Wei; Lei Wei; Taotao Wei; Yongjie Wei; Oliver H Weiergräber; Conrad C Weihl; Günther Weindl; Ralf Weiskirchen; Alan Wells; Runxia H Wen; Xin Wen; Antonia Werner; Beatrice Weykopf; Sally P Wheatley; J Lindsay Whitton; Alexander J Whitworth; Katarzyna Wiktorska; Manon E Wildenberg; Tom Wileman; Simon Wilkinson; Dieter Willbold; Brett Williams; Robin S B Williams; Roger L Williams; Peter R Williamson; Richard A Wilson; Beate Winner; Nathaniel J Winsor; Steven S Witkin; Harald Wodrich; Ute Woehlbier; Thomas Wollert; Esther Wong; Jack Ho Wong; Richard W Wong; Vincent Kam Wai Wong; W Wei-Lynn Wong; An-Guo Wu; Chengbiao Wu; Jian Wu; Junfang Wu; Kenneth K Wu; Min Wu; Shan-Ying Wu; Shengzhou Wu; Shu-Yan Wu; Shufang Wu; William K K Wu; Xiaohong Wu; Xiaoqing Wu; Yao-Wen Wu; Yihua Wu; Ramnik J Xavier; Hongguang Xia; Lixin Xia; Zhengyuan Xia; Ge Xiang; Jin Xiang; Mingliang Xiang; Wei Xiang; Bin Xiao; Guozhi Xiao; Hengyi Xiao; Hong-Tao Xiao; Jian Xiao; Lan Xiao; Shi Xiao; Yin Xiao; Baoming Xie; Chuan-Ming Xie; Min Xie; Yuxiang Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Congfeng Xu; En Xu; Haoxing Xu; Jing Xu; JinRong Xu; Liang Xu; Wen Wen Xu; Xiulong Xu; Yu Xue; Sokhna M S Yakhine-Diop; Masamitsu Yamaguchi; Osamu Yamaguchi; Ai Yamamoto; Shunhei Yamashina; Shengmin Yan; Shian-Jang Yan; Zhen Yan; Yasuo Yanagi; Chuanbin Yang; Dun-Sheng Yang; Huan Yang; Huang-Tian Yang; Hui Yang; Jin-Ming Yang; Jing Yang; Jingyu Yang; Ling Yang; Liu Yang; Ming Yang; Pei-Ming Yang; Qian Yang; Seungwon Yang; Shu Yang; Shun-Fa Yang; Wannian Yang; Wei Yuan Yang; Xiaoyong Yang; Xuesong Yang; Yi Yang; Ying Yang; Honghong Yao; Shenggen Yao; Xiaoqiang Yao; Yong-Gang Yao; Yong-Ming Yao; Takahiro Yasui; Meysam Yazdankhah; Paul M Yen; Cong Yi; Xiao-Ming Yin; Yanhai Yin; Zhangyuan Yin; Ziyi Yin; Meidan Ying; Zheng Ying; Calvin K Yip; Stephanie Pei Tung Yiu; Young H Yoo; Kiyotsugu Yoshida; Saori R Yoshii; Tamotsu Yoshimori; Bahman Yousefi; Boxuan Yu; Haiyang Yu; Jun Yu; Jun Yu; Li Yu; Ming-Lung Yu; Seong-Woon Yu; Victor C Yu; W Haung Yu; Zhengping Yu; Zhou Yu; Junying Yuan; Ling-Qing Yuan; Shilin Yuan; Shyng-Shiou F Yuan; Yanggang Yuan; Zengqiang Yuan; Jianbo Yue; Zhenyu Yue; Jeanho Yun; Raymond L Yung; David N Zacks; Gabriele Zaffagnini; Vanessa O Zambelli; Isabella Zanella; Qun S Zang; Sara Zanivan; Silvia Zappavigna; Pilar Zaragoza; Konstantinos S Zarbalis; Amir Zarebkohan; Amira Zarrouk; Scott O Zeitlin; Jialiu Zeng; Ju-Deng Zeng; Eva Žerovnik; Lixuan Zhan; Bin Zhang; Donna D Zhang; Hanlin Zhang; Hong Zhang; Hong Zhang; Honghe Zhang; Huafeng Zhang; Huaye Zhang; Hui Zhang; Hui-Ling Zhang; Jianbin Zhang; Jianhua Zhang; Jing-Pu Zhang; Kalin Y B Zhang; Leshuai W Zhang; Lin Zhang; Lisheng Zhang; Lu Zhang; Luoying Zhang; Menghuan Zhang; Peng Zhang; Sheng Zhang; Wei Zhang; Xiangnan Zhang; Xiao-Wei Zhang; Xiaolei Zhang; Xiaoyan Zhang; Xin Zhang; Xinxin Zhang; Xu Dong Zhang; Yang Zhang; Yanjin Zhang; Yi Zhang; Ying-Dong Zhang; Yingmei Zhang; Yuan-Yuan Zhang; Yuchen Zhang; Zhe Zhang; Zhengguang Zhang; Zhibing Zhang; Zhihai Zhang; Zhiyong Zhang; Zili Zhang; Haobin Zhao; Lei Zhao; Shuang Zhao; Tongbiao Zhao; Xiao-Fan Zhao; Ying Zhao; Yongchao Zhao; Yongliang Zhao; Yuting Zhao; Guoping Zheng; Kai Zheng; Ling Zheng; Shizhong Zheng; Xi-Long Zheng; Yi Zheng; Zu-Guo Zheng; Boris Zhivotovsky; Qing Zhong; Ao Zhou; Ben Zhou; Cefan Zhou; Gang Zhou; Hao Zhou; Hong Zhou; Hongbo Zhou; Jie Zhou; Jing Zhou; Jing Zhou; Jiyong Zhou; Kailiang Zhou; Rongjia Zhou; Xu-Jie Zhou; Yanshuang Zhou; Yinghong Zhou; Yubin Zhou; Zheng-Yu Zhou; Zhou Zhou; Binglin Zhu; Changlian Zhu; Guo-Qing Zhu; Haining Zhu; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Yanping Zhu; Yushan Zhu; Haixia Zhuang; Xiaohong Zhuang; Katarzyna Zientara-Rytter; Christine M Zimmermann; Elena Ziviani; Teresa Zoladek; Wei-Xing Zong; Dmitry B Zorov; Antonio Zorzano; Weiping Zou; Zhen Zou; Zhengzhi Zou; Steven Zuryn; Werner Zwerschke; Beate Brand-Saberi; X Charlie Dong; Chandra Shekar Kenchappa; Zuguo Li; Yong Lin; Shigeru Oshima; Yueguang Rong; Judith C Sluimer; Christina L Stallings; Chun-Kit Tong
Journal:  Autophagy       Date:  2021-02-08       Impact factor: 13.391

5.  Structure and properties of slow-resorbing nanofibers obtained by (co-axial) electrospinning as tissue scaffolds in regenerative medicine.

Authors:  Andrzej Hudecki; Joanna Gola; Saeid Ghavami; Magdalena Skonieczna; Jarosław Markowski; Wirginia Likus; Magdalena Lewandowska; Wojciech Maziarz; Marek J Los
Journal:  PeerJ       Date:  2017-12-18       Impact factor: 2.984

Review 6.  A review and outlook in the treatment of osteosarcoma and other deep tumors with photodynamic therapy: from basic to deep.

Authors:  Wei Yu; Jian Zhu; Yitian Wang; Junjie Wang; Weijing Fang; Kaishun Xia; Jianlin Shao; Minzu Wu; Bing Liu; Chengzhen Liang; Chengyi Ye; Huimin Tao
Journal:  Oncotarget       Date:  2017-06-13

7.  A novel approach to low-temperature synthesis of cubic HfO2 nanostructures and their cytotoxicity.

Authors:  Neeraj Kumar; Blassan Plackal Adimuriyil George; Heidi Abrahamse; Vyom Parashar; Suprakas Sinha Ray; Jane Catherine Ngila
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

Review 8.  The Role of Reactive Oxygen Species (ROS) in the Biological Activities of Metallic Nanoparticles.

Authors:  Ahmed Abdal Dayem; Mohammed Kawser Hossain; Soo Bin Lee; Kyeongseok Kim; Subbroto Kumar Saha; Gwang-Mo Yang; Hye Yeon Choi; Ssang-Goo Cho
Journal:  Int J Mol Sci       Date:  2017-01-10       Impact factor: 5.923

9.  Biophysical, docking, and cellular studies on the effects of cerium oxide nanoparticles on blood components: in vitro.

Authors:  Neda Eskandari; Mohammad Mahdi Nejadi Babadaei; Sanaz Nikpur; Ghazal Ghasrahmad; Farnoosh Attar; Masoumeh Heshmati; Keivan Akhtari; Seyed Mahdi Rezayat Sorkhabadi; Seyyedeh Elaheh Mousavi; Mojtaba Falahati
Journal:  Int J Nanomedicine       Date:  2018-08-10

10.  Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells.

Authors:  Jingyao Chen; Yanfeng Zhu; Weiwei Zhang; Xiaoli Peng; Jie Zhou; Fei Li; Bin Han; Xin Liu; Yu Ou; Xiaoping Yu
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.